Collagenous colitis

COLITCOLLAG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K52.88 Cause of death: ICD-10 — K52.88 2 out of 7 registries used, show all original rules.	4338
4. Check minimum number of events None	4338
5. Include endpoints None	4338
6. Filter based on genotype QC (FinnGen only)	3942

Control definitions (FinnGen only)

Control exclude: K11_ENERCOLNONINF

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K52
Name in latin: Alia gastroenteritis et/sive colitis non infectiosa specificata

NAME	COLITCOLLAG
CONTROL_EXCLUDE	K11_ENERCOLNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K5288
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K5288
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Collagenous colitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3942	2674	1268
Unadjusted period prevalence (%)	0.83	0.95	0.58
Median age at first event (years)	61.33	59.89	64.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4068: Matched controls
40680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L01BB02

ATC

mercaptopurine; oral

54.1

318.0

181

D11

ICPC

Diarrhoea

4.3

317.6

1020

2944

UJF30

NOMESCO Finland

Ileoscopy through colon

8.5

307.7

1305

2141

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

229.2

307.7

217

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

4.5

307.7

1476

4610

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4503599627370496.0

307.7

4067

A07EC02

ATC

mesalazine; oral, rectal

107.5

307.7

1310

179

UJF32

NOMESCO Finland

Coloscopy

7.1

307.7

2347

6583

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

7.4

307.7

675

1072

A07EA06

ATC

budesonide; oral, local oral

204.8

307.7

1787

155

UJF92

NOMESCO Finland

Capsular endoscopy

13.9

307.7

332

258

K51.5

ICD-10 Finland

Left sided colitis

1937.9

307.7

493

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

307.7

722

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

677.8

307.7

678

A06AC01

ATC

ispaghula (psylla seeds); oral

4.3

307.7

1993

7496

A07EA02

ATC

hydrocortisone; rectal

41.5

307.7

275

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.9

307.7

1989

8029

L04AX01

ATC

azathioprine; systemic

11.8

307.7

489

465

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

59.0

307.7

978

217

C10AC01

ATC

colestyramine; oral

20.8

307.7

685

393

K59.1

ICD-10 Finland

Functional diarrhoea

9.5

307.7

877

1147

K51.8

ICD-10 Finland

Other ulcerative colitis

1054.6

303.9

294

D94

ICPC

Chronic enteritis/ulcerative colitis

59.9

268.8

150

H02AB06

ATC

prednisolone; systemic

3.0

246.5

2542

14506

K50.8

ICD-10 Finland

Other Crohn disease

+∞

231.5

220

K50.9

ICD-10 Finland

Crohn disease, unspecified

788.3

229.6

224

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

4.4

223.0

633

1637

K50.0

ICD-10 Finland

Crohn disease of small intestine

+∞

213.4

203

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

213.2

2048

10986

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

33.1

185.5

119

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

178.9

874

3222

J01MA02

ATC

ciprofloxacin; systemic

2.5

178.3

1962

10964

P01AB01

ATC

metronidazole; oral, rectal

2.5

175.1

2077

11986

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

173.2

165

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

1816.7

173.1

167

A06AC51

ATC

ispaghula, combinations; oral

4.7

160.8

403

937

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

158.4

151

K50.1

ICD-10 Finland

Crohn disease of large intestine

1582.3

154.1

149

A07DA03

ATC

loperamide; oral

5.8

153.9

292

532

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

147.2

2330

14865

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

146.7

1808

10375

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.9

144.2

811

3204

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

+∞

142.5

136

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

248.7

141.1

144

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

239.8

135.9

139

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

135.5

609

2113

A02BC02

ATC

pantoprazole; systemic

2.5

132.1

3149

23427

H02AB07

ATC

prednisone; oral

2.8

129.8

775

3147

K51

ICD-10 Finland

Ulcerative colitis

173.1

128.2

134

N02AX02

ATC

tramadol; systemic, rectal

2.1

121.1

2023

12831

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

120.6

1150

5815

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

66.0

118.2

A02BC05

ATC

esomeprazole; systemic

2.1

109.0

1929

12346

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

18.1

108.0

N03AX16

ATC

[U] pregabalin

2.2

106.0

1179

6306

R19.4

ICD-10 Finland

Change in bowel habit

4.7

105.6

257

580

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

531.5

105.2

104

A07EC01

ATC

sulfasalazine; oral, rectal

3.2

104.9

465

1589

N06AX11

ATC

mirtazapine; oral

2.1

104.1

1681

10354

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

101.1

743

3311

ZX120

NOMESCO Finland

Intravenous

2.9

100.3

533

2016

JF1BD

NOMESCO Finland

Very extensive small bowel CT

22.9

98.9

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

21.5

96.5

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

91.2

1190

6708

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.4

90.4

184

356

L04AB04

ATC

adalimumab; parenteral

5.7

90.0

170

307

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

88.6

946

4928

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.6

86.8

213

483

WX002

NOMESCO Finland

Sedation and analgesia

2.2

84.5

948

5024

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

83.6

1116

6311

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

5.1

83.6

179

362

A07EA01

ATC

prednisolone; oral, rectal

45.1

82.6

JF1AD

NOMESCO Finland

Small bowel CT

11.6

82.0

L04AC05

ATC

ustekinumab; parenteral

30.4

82.0

A02BC03

ATC

lansoprazole; oral

2.0

81.0

1309

7906

JFF10

NOMESCO Finland

Loop enterostomy

13.2

77.7

K52

ICD-10 Finland

Other noninfective gastroenteritis and colitis

37.4

77.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

76.9

509

2140

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

265.6

76.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

75.8

258

743

N06AX21

ATC

duloxetine; oral

2.3

75.1

648

3072

K90.0

ICD-10 Finland

Coeliac disease

4.2

73.4

202

500

4AA12, ,

NOMESCO Finland

40.4

72.3

L04AB02

ATC

infliximab; parenteral

27.5

72.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

70.7

1912

13441

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

70.3

1156

6962

R50.9

ICD-10 Finland

Fever, unspecified

2.2

69.9

733

3755

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.2

69.4

299

998

J01MA12

ATC

levofloxacin; systemic

2.1

68.8

841

4563

Z93.2

ICD-10 Finland

Ileostomy status

20.2

67.9

N05CF01

ATC

zopiclone; oral

1.8

66.7

1419

9241

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

65.5

891

5012

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

65.5

1874

13293

N05BA04

ATC

oxazepam; oral

1.9

65.4

1218

7602

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

64.9

705

3652

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

+∞

63.7

A02BC01

ATC

omeprazole; systemic

1.8

62.6

1208

7604

R11

ICD-10 Finland

Nausea and vomiting

2.4

61.8

478

2150

R53

ICD-10 Finland

Malaise and fatigue

1.8

61.6

1177

7382

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

61.5

430

1847

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

9.4

61.0

N02BE01

ATC

paracetamol; systemic, rectal

2.6

61.0

3738

33155

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

+∞

59.5

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

59.5

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

59.3

546

2642

D01

ICPC

Abdominal pain/cramps general

2.1

59.3

625

3191

ZXE00

NOMESCO Finland

One hour or less

1.7

59.2

1637

11402

N05AH04

ATC

quetiapine; oral

2.0

58.9

802

4496

N06AX16

ATC

venlafaxine; oral

2.1

58.6

685

3635

E0000UV, ,

ATC

1.7

58.3

1816

13051

J01DB01

ATC

cefalexin; oral

2.0

58.0

3419

29405

M79.6

ICD-10 Finland

Pain in limb

1.7

57.8

1941

14223

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

+∞

57.4

R51.80

ICD-10 Finland

Headache

2.0

56.4

757

4215

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

56.3

494

2341

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

55.3

1499

10331

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

54.3

205

630

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

53.6

244

839

L04AX03

ATC

methotrexate; systemic

2.2

53.5

477

2274

D07AC01

ATC

betamethasone; topical

1.7

53.1

1548

10850

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

52.9

480

2304

M54.5

ICD-10 Finland

Low back pain

1.7

52.8

1607

11386

J02AC01

ATC

fluconazole; systemic

1.7

52.7

1710

12321

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

52.6

349

1460

N02AA05

ATC

oxycodone; systemic

1.9

51.8

816

4779

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

51.8

511

2535

N06AB04

ATC

citalopram; systemic

1.8

50.5

920

5633

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

+∞

50.1

H02AB09

ATC

hydrocortisone; systemic

3.9

49.8

151

401

AA1AD

NOMESCO Finland

CT of head and brain

1.7

49.4

1246

8366

A07AA09

ATC

vancomycin; oral

5.5

49.1

179

S18

ICPC

Laceration/cut

1.6

48.9

1980

14988

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

48.6

992

6273

E87.6

ICD-10 Finland

Hypokalaemia

3.2

48.4

202

660

H02AB04

ATC

methylprednisolone; systemic

2.0

48.3

645

3569

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

48.3

355

1555

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

48.0

590

3171

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

47.5

289

1158

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

47.4

509

2604

3042, ,

Kela drug reimbursment

+∞

47.0

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

7.8

46.3

253, ,

Kela drug reimbursment

+∞

45.9

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

4.4

45.9

117

273

N06AB10

ATC

escitalopram; oral

1.8

45.8

881

5464

Z3231

NOMESCO Finland

Registered nurse

1.7

45.1

1124

7487

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.6

44.8

282

1148

K92.1

ICD-10 Finland

Melaena

2.7

44.8

257

1000

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

44.5

486

2499

WX402

NOMESCO Finland

General anaesthesia

1.7

44.1

959

6148

B01AB05

ATC

enoxaparin; parenteral

1.6

44.0

1323

9239

R06.0

ICD-10 Finland

Dyspnoea

1.7

43.8

1168

7909

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

10.5

43.8

M03BX02

ATC

tizanidine; oral

1.6

43.4

2501

20348

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

43.1

489

2549

L04AD01

ATC

ciclosporin; systemic

4.3

42.7

110

259

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

42.2

380

1811

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.4

42.1

106

245

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

42.0

1033

6835

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

42.0

1712

12823

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

42.0

907

5795

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

+∞

41.7

N03AX12

ATC

[U] gabapentin; oral

1.8

41.5

708

4223

K56.7

ICD-10 Finland

Ileus, unspecified

4.5

41.3

102

232

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

41.3

1825

13905

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.6

41.3

216

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

41.2

476

2494

N05CF02

ATC

zolpidem; oral

1.8

41.2

754

4591

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

41.0

482

2543

WVA20

NOMESCO Finland

Medicine administration

3.3

40.8

157

488

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

40.2

460

2402

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

40.1

806

5040

K50

ICD-10 Finland

Crohn disease [regional enteritis]

207.0

39.9

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

39.8

323

1474

A07AA11

ATC

rifaximin; oral

11.2

39.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.1

39.7

115

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

+∞

39.6

A02BA02

ATC

ranitidine; systemic

1.7

39.2

784

4891

K29.7

ICD-10 Finland

Gastritis, unspecified

3.0

39.2

183

638

D07AD01

ATC

clobetasol; topical

1.8

39.1

738

4529

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.5

39.0

214

Z71.8

ICD-10 Finland

Other specified counselling

1.6

38.9

1438

10481

N06AX12

ATC

bupropion; oral

2.3

38.8

325

1503

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

38.6

1215

8521

Z2221

NOMESCO Finland

Medical doctor

1.6

38.6

1107

7590

N06AA09

ATC

amitriptyline; systemic

2.0

38.5

432

2239

P01BA02

ATC

hydroxychloroquine; oral

2.1

38.5

389

1939

A05AA02

ATC

ursodeoxycholic acid; oral

4.3

38.4

233

JAH00

NOMESCO Finland

Laparotomy

3.3

38.3

144

441

JN4AD

NOMESCO Finland

Body CT examination

1.9

38.3

503

2754

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.5

38.3

248

1023

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

38.2

1179

8226

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

38.2

792

4986

SPAT1263

SPAT

Sampling

1.5

37.8

1676

12701

N06AB06

ATC

sertraline; oral

1.9

37.7

506

2789

R19.5

ICD-10 Finland

Other faecal abnormalities

3.8

37.6

116

312

M25.5

ICD-10 Finland

Pain in joint

1.6

37.4

1397

10181

C07AA05

ATC

propranolol; systemic

1.7

37.4

851

5492

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

37.3

2101

16746

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

37.3

844

5439

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

37.3

409

2101

R42

ICD-10 Finland

Dizziness and giddiness

1.6

37.2

987

6629

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

36.9

414

2143

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

36.8

370

1839

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

36.6

199

752

ZXD05

NOMESCO Finland

Urgent procedure

1.6

36.4

1175

8271

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

36.1

246

1038

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

36.0

564

3265

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

35.9

730

4563

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

35.8

953

6395

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

35.8

540

3090

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

35.7

261

1137

JFF13

NOMESCO Finland

Terminal enterostomy

13.9

35.6

L04AG05

ATC

vedolizumab; parenteral

+∞

35.5

R10.0

ICD-10 Finland

Acute abdomen

2.9

35.4

172

613

K61.0

ICD-10 Finland

Anal abscess

4.4

35.3

206

N02BF01

ATC

gabapentin; oral

1.9

35.3

479

2648

M01AH05

ATC

etoricoxib; oral

1.5

35.0

2488

20705

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

35.0

2886

24802

R4110

NOMESCO Finland

Physiotherapy

1.6

34.8

1140

8035

J01FF01

ATC

clindamycin; systemic

1.6

34.7

1076

7485

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

34.7

621

3740

C07AB07

ATC

bisoprolol; oral

1.5

34.7

1898

14950

R03AC02

ATC

salbutamol; inhalant

1.5

34.7

2213

17992

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

34.5

1514

11382

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

34.5

1477

11047

R15

ICD-10 Finland

Faecal incontinence

2.9

34.4

166

589

D07AC13

ATC

mometasone; topical

1.6

34.3

1149

8136

R52.9

ICD-10 Finland

Pain, unspecified

1.9

34.3

466

2576

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

33.8

114

326

N05CD07

ATC

temazepam; oral

1.9

33.7

468

2604

E86

ICD-10 Finland

Volume depletion

3.3

33.7

130

405

K30

ICD-10 Finland

Functional dyspepsia

1.9

33.7

510

2918

J01FA10

ATC

azithromycin; systemic

1.5

33.7

2272

18633

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

+∞

33.4

R06AE07

ATC

cetirizine; oral

1.5

33.1

1787

13990

UKC02

NOMESCO Finland

Cystoscopy

1.8

32.9

593

3575

A04

ICPC

Weakness/tiredness general

1.7

32.9

703

4446

K83.0

ICD-10 Finland

Cholangitis

4.3

32.8

197

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

8.8

32.8

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.8

32.7

157

Z01.2

ICD-10 Finland

Dental examination

1.5

32.7

1881

14904

Z3226

NOMESCO Finland

Physiotherapist

1.7

32.4

742

4776

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

32.3

658

4104

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

13.0

32.3

UJF30, ,

SPAT

5.1

32.3

132

D06

ICPC

Abdominal pain localized other

1.9

32.2

414

2245

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

32.1

1974

15826

B81

ICPC

Anaemia vit B12/folate deficiency

2.7

32.1

178

680

TGC00

NOMESCO Finland

Bronchial lavation

3.3

32.1

125

392

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

31.9

921

6282

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

31.7

576

3477

N02BF02

ATC

pregabalin; oral

2.1

31.7

315

1557

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

31.5

799

5276

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

31.5

216

914

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.8

31.5

166

618

N30.0

ICD-10 Finland

Acute cystitis

1.6

31.4

772

5058

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

31.3

883

5983

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

31.3

686

4361

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

31.3

260

1196

R4190

NOMESCO Finland

Nutritional therapy

2.6

31.3

186

736

WZC30

NOMESCO Finland

Teaching

1.7

31.2

685

4358

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.8

31.0

161

594

M48.0

ICD-10 Finland

Spinal stenosis

1.8

30.9

515

3029

J01AA02

ATC

doxycycline; systemic

1.6

30.8

3080

27135

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

30.6

1018

7165

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

30.4

749

4906

C03CA01

ATC

furosemide; systemic

1.5

30.3

1138

8222

256, ,

Kela drug reimbursment

+∞

30.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

30.2

492

2874

G44.2

ICD-10 Finland

Tension-type headache

1.7

30.2

586

3602

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

30.1

330

1690

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

30.1

411

2271

J01MA14

ATC

moxifloxacin; systemic

2.0

30.1

367

1953

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.0

30.0

215

JHA00

NOMESCO Finland

Anal or perianal incision

4.3

30.0

181

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

29.8

172

670

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

29.8

519

3092

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

29.7

200

839

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

29.7

1233

9094

L03

ICPC

Low back symptom/complaint

1.5

29.7

1226

9032

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

29.4

128

429

WX892

NOMESCO Finland

Monitored bed care

2.1

29.4

314

1594

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

11.1

29.3

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

29.2

1162

8488

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

29.1

2840

24704

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

29.1

262

1246

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

28.9

144

520

UJF02

NOMESCO Finland

Peroral enteroscopy

7.8

28.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

28.6

425

2411

R01AD08

ATC

fluticasone; nasal

1.5

28.6

1116

8112

A07AA02

ATC

nystatin; oral

2.2

28.5

259

1236

A01

ICPC

Pain general/multiple sites

1.8

28.4

461

2687

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

28.4

258

1231

L04AA01

ATC

[U] ciclosporin

4.1

28.3

189

M79.1

ICD-10 Finland

Myalgia

1.7

28.3

632

4028

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

28.2

905

6301

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

+∞

28.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

28.1

1260

9416

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

6.0

28.1

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

28.0

1388

10584

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

27.8

365

1989

XKD00

NOMESCO Finland

Uroflowmetry

1.8

27.8

502

3019

K60.3

ICD-10 Finland

Anal fistula

3.8

27.8

232

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

27.8

152

577

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

27.3

1039

7498

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

27.1

1084

7902

L17

ICPC

Foot/toe symptom/complaint

1.5

27.1

1252

9401

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

27.1

776

5258

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

27.1

714

4743

TJF80

NOMESCO Finland

Ostomy education

4.6

27.1

141

R01AD09

ATC

mometasone; nasal

1.4

27.0

1779

14282

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

26.9

267

1317

N06AB03

ATC

fluoxetine; oral

1.7

26.9

496

2999

L04AA06

ATC

mycophenolic acid; systemic

3.4

26.9

290

SPAT1240

SPAT

Therapeutic discussion

1.8

26.8

420

2420

N04BC05

ATC

pramipexole; oral

1.9

26.7

331

1770

M01AE02

ATC

naproxen; oral, rectal

1.4

26.6

2194

18322

S97

ICPC

Chronic ulcer skin

2.1

26.4

265

1314

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

26.3

193

842

JAH01

NOMESCO Finland

Laparoscopy

2.3

26.2

197

868

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

26.2

562

3540

JFH10

NOMESCO Finland

Total colectomy and ileostomy

37.0

26.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

26.1

118

404

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

26.0

2625

22696

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

26.0

1117

8253

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

26.0

268

1342

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

25.9

2133

17777

A03FA02

ATC

cisapride; oral, rectal

2.0

25.5

308

1631

M01AB05

ATC

diclofenac; systemic, rectal

1.4

25.5

2544

21905

A01AB09

ATC

miconazole; local oral

1.9

25.5

352

1949

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

25.4

149

586

M01AH01

ATC

celecoxib; oral

1.6

25.3

704

4729

N05BA01

ATC

diazepam; systemic, rectal

1.7

25.2

507

3138

M04AA01

ATC

allopurinol; systemic

1.7

25.2

462

2787

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

25.1

131

485

G47.3

ICD-10 Finland

Sleep apnoea

1.5

25.1

845

5927

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

25.0

347

1924

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

24.8

190

844

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

24.8

207

954

L01BA01

ATC

methotrexate; systemic

2.5

24.8

165

689

D99

ICPC

Disease digestive system other

4.4

24.8

143

A02BC04

ATC

rabeprazole; oral

1.8

24.6

369

2097

D17

ICPC

Incontinence of bowel

4.1

24.6

165

6419

FHL

Other measure in this category

43.1

24.5

J01FA09

ATC

clarithromycin; systemic

1.5

24.4

1187

8962

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.4

24.4

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

24.2

437

2623

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

7.6

24.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

24.1

128

479

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

24.0

644

4285

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

24.0

495

3083

N06AX26

ATC

vortioxetine; oral

1.9

23.9

317

1731

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

23.8

1769

14400

N03AE01

ATC

clonazepam; systemic

2.1

23.8

245

1226

F34.1

ICD-10 Finland

Dysthymia

2.4

23.7

166

710

J01CA04

ATC

amoxicillin; systemic

1.5

23.6

3228

29237

3AC01, ,

NOMESCO Finland

4.7

23.6

116

K63.9

ICD-10 Finland

Disease of intestine, unspecified

5.9

23.5

L28

ICPC

Limited function/disability (L)

1.5

23.5

775

5403

D07AB08

ATC

desonide; topical

1.7

23.4

420

2516

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

23.2

294

1583

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

23.2

131

506

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

23.1

241

1211

J01DA01

ATC

[U] cefalexin

1.4

23.0

2345

20084

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

23.0

518

3300

N06AX03

ATC

mianserin; oral

2.2

22.9

201

946

A08.5

ICD-10 Finland

Other specified intestinal infections

5.5

22.9

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

22.7

137

546

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

22.7

158

674

SFA10

NOMESCO Finland

One-surface restoration

1.4

22.7

2122

17901

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

22.6

188

865

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

22.5

979

7215

L04AB06

ATC

golimumab; parenteral

5.0

22.5

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

8.8

22.4

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

22.4

395

2355

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

22.3

276

1473

F32

ICD-10 Finland

Depressive episode

2.1

22.2

221

1092

R55

ICD-10 Finland

Syncope and collapse

1.7

22.2

427

2608

M79.7

ICD-10 Finland

Fibromyalgia

2.3

22.2

162

706

C05AA08

ATC

fluocortolone; rectal, topical

1.6

22.1

508

3250

N03AX09

ATC

lamotrigine; oral

2.2

22.1

194

913

A04AA01

ATC

ondansetron; systemic, rectal

1.8

22.1

345

1984

SPAT1254

SPAT

Administration of medicine

1.6

22.0

564

3706

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

21.9

379

2246

K52.8

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

+∞

21.9

R13

ICD-10 Finland

Dysphagia

1.9

21.9

301

1664

ZXA10

NOMESCO Finland

Bilateral

1.5

21.7

699

4837

SPAT1262

SPAT

Handing over of treatment supplies

1.6

21.7

631

4270

B01AB10

ATC

tinzaparin; parenteral

1.7

21.6

439

2720

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

21.6

251

1312

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

21.5

190

896

M01AB55

ATC

diclofenac, combinations; oral

1.9

21.5

271

1456

L04AD02

ATC

tacrolimus; systemic

4.2

21.4

134

JFB00

NOMESCO Finland

Partial resection of small intestine

3.5

21.4

211

R03BB04

ATC

tiotropium bromide; inhalant

1.8

21.4

371

2200

K02.1

ICD-10 Finland

Caries of dentine

1.4

21.3

2246

19229

K58.1

ICD-10 Finland

Irritable bowel syndrome with predominant diarrhoea [IBS-D]

4.5

21.2

118

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

21.2

238

1228

D18

ICPC

Change in faeces/bowel movements

2.5

21.2

129

517

K58

ICD-10 Finland

Irritable bowel syndrome

2.6

21.1

123

482

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

21.1

314

1778

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

21.1

1479

11848

J01FA06

ATC

roxithromycin; oral

1.4

21.1

1498

12026

J20

ICD-10 Finland

Acute bronchitis

1.7

21.1

414

2541

E000001, ,

ATC

1.5

21.0

728

5114

D93

ICPC

Irritable bowel syndrome

3.4

21.0

223

WX320

NOMESCO Finland

Spinalanesthesy

1.5

21.0

946

7006

A03BA03

ATC

hyoscyamine; oral

4.6

21.0

107

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

20.9

287

1585

M05BA04

ATC

alendronic acid; oral

1.7

20.9

368

2191

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

20.9

1117

8537

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

20.8

128

515

L04AA33

ATC

[U] vedolizumab

+∞

20.8

M02AA07

ATC

piroxicam; topical

1.4

20.8

1344

10614

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

20.8

212

1057

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

20.7

268

1452

R52.2

ICD-10 Finland

Other chronic pain

2.2

20.7

170

779

K62.4

ICD-10 Finland

Stenosis of anus and rectum

8.7

20.6

RD210, ,

NOMESCO Finland

3.2

20.6

256

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

20.5

184

873

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

20.5

298

1675

UJD02

NOMESCO Finland

Gastroscopy

2.1

20.5

191

920

1370

FHL

Colonoscopy, whole colon

8.2

20.5

SPAT1260

SPAT

Consultation of another employee

1.5

20.5

660

4564

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

20.5

373

2242

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

20.5

424

2639

SFA20

NOMESCO Finland

Two-surface restoration

1.4

20.4

2226

19099

J05AB01

ATC

aciclovir; systemic

1.5

20.4

845

6152

L04AA13

ATC

[U] leflunomide

2.6

20.4

114

438

J01EA01

ATC

trimethoprim; systemic

1.4

20.4

1017

7669

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

20.3

248

1317

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

20.3

881

6473

SPAT1131

SPAT

Colonoscopy

2.5

20.3

132

546

A46

ICD-10 Finland

Erysipelas

1.6

20.3

536

3544

ZY010

NOMESCO Finland

Hospital outpatient

2.1

20.3

205

1019

4AB02, ,

NOMESCO Finland

16.1

20.1

M01AC06

ATC

meloxicam; systemic, rectal

1.4

20.0

1366

10874

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

19.9

780

5613

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

19.9

371

2243

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

19.9

104

386

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

4.4

19.9

112

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

19.8

117

462

4AA33, ,

NOMESCO Finland

+∞

19.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

19.8

218

1118

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.8

19.7

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

19.7

365

2204

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

19.7

481

3121

R02

ICPC

Shortness of breath/dyspnoea

1.6

19.6

546

3653

JFH11

NOMESCO Finland

Laparoscopic colectomy

200.9

19.6

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.8

19.4

335

N06AB05

ATC

paroxetine; oral

1.9

19.4

236

1252

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

19.4

1071

8213

J05AB11

ATC

valaciclovir; oral

1.6

19.2

565

3824

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

19.2

502

3307

JN4BD

NOMESCO Finland

Extensive body CT

1.7

19.2

375

2296

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

19.2

388

2398

C01DA14

ATC

isosorbide mononitrate; oral

1.6

19.1

515

3420

R07.3

ICD-10 Finland

Other chest pain

1.7

19.0

408

2562

M01AH02

ATC

rofecoxib; oral

1.6

18.9

468

3043

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

18.9

126

527

JHD00

NOMESCO Finland

Anal dilatation

4.5

18.9

100

R35

ICD-10 Finland

Polyuria

1.9

18.8

257

1416

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.0

18.8

134

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

18.7

359

R60.0

ICD-10 Finland

Localized oedema

1.6

18.6

496

3283

N07BA03

ATC

varenicline; oral

2.1

18.6

178

867

L13

ICPC

Hip symptom/complaint

1.5

18.5

786

5736

K65.0

ICD-10 Finland

Acute peritonitis

4.0

18.4

132

R03DC03

ATC

montelukast; oral

1.5

18.4

634

4441

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.0

18.3

275

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

18.3

245

1343

R05

ICPC

Cough

1.4

18.3

979

7456

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

18.2

661

4678

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

18.0

255

1422

P03

ICPC

Feeling depressed

1.7

18.0

383

2398

R51

ICD-10 Finland

Headache

1.9

18.0

225

1206

P06

ICPC

Sleep disturbance

1.6

17.9

498

3327

A06AD11

ATC

lactulose; oral

1.5

17.9

525

3550

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

17.8

271

1544

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

17.8

273

1559

J02AC02

ATC

itraconazole; systemic

1.5

17.8

654

4636

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

17.8

326

1960

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

17.8

234

1274

D07AA02

ATC

hydrocortisone; topical

1.6

17.8

509

3423

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.9

17.8

296

H03AA01

ATC

levothyroxine sodium; systemic

1.4

17.7

918

6946

A28

ICPC

Limited function/disability NOS

1.5

17.7

684

4900

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

17.6

396

2513

J45

ICD-10 Finland

Asthma

1.6

17.6

404

2578

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

36.9

17.6

K56.0

ICD-10 Finland

Paralytic ileus

4.3

17.6

106

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

17.6

348

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

17.6

169

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

17.5

127

552

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

17.5

1455

11881

R01AD12

ATC

fluticasone furoate; nasal

1.4

17.5

1163

9171

G04CA02

ATC

tamsulosin; oral

1.5

17.5

635

4491

127

Kela drug reimbursment

Transplant complication

3.2

17.5

209

S29

ICPC

Skin symptom/complaint other

1.4

17.5

799

5908

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

17.5

139

629

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.1

17.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

17.4

981

7527

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

17.4

174

862

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

17.3

361

2247

R05

ICD-10 Finland

Cough

1.4

17.3

834

6223

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

17.3

1573

13012

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.1

17.3

116

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

17.3

216

1157

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

17.2

546

3752

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

17.2

549

3778

R06AX27

ATC

desloratadine; oral

1.4

17.2

1075

8387

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.1

17.2

242

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

17.2

152

718

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

17.1

271

1563

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

17.1

182

922

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

17.1

252

1423

N05BA12

ATC

alprazolam; oral

1.6

17.1

376

2374

M01AX17

ATC

nimesulide; oral

1.4

17.0

862

6490

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

17.0

302

1802

SPAT1301

SPAT

No procedures

1.4

16.9

1142

9018

XQ800

NOMESCO Finland

Prick test

1.8

16.9

276

1608

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

16.8

540

3720

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.8

1496

12324

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

16.8

286

1686

A98

ICPC

Health maint/preventive medicine

2.0

16.8

3915

37690

JK3MN

NOMESCO Finland

Bile absorbtion isotope examination

63.6

16.7

R01AD58

ATC

fluticasone, combinations; nasal

1.4

16.7

918

7006

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

16.7

A07EC03

ATC

olsalazine; oral

+∞

16.7

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

16.6

451

2993

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.1

16.6

231

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.6

16.6

D82

ICPC

Teeth/gum disease

1.3

16.6

1388

11324

R4110, ,

SPAT

1.5

16.5

540

3735

SPAT1312

SPAT

General health counselling

1.4

16.5

1153

9149

XF404

NOMESCO Finland

Ambulatory ECG

1.7

16.5

313

1901

Z2446

NOMESCO Finland

Social worker

1.8

16.4

240

1351

M02AA10

ATC

ketoprofen; topical

1.5

16.4

589

4151

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

16.4

276

1620

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

16.4

132

601

L08

ICPC

Shoulder symptom/complaint

1.4

16.4

885

6732

S06.0

ICD-10 Finland

Concussion

1.6

16.4

405

2631

XF402

NOMESCO Finland

ECG with work load test

1.6

16.4

376

2399

UJF34

NOMESCO Finland

Left colonoscopy

4.7

16.3

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

16.3

108

C07AB02

ATC

metoprolol; systemic

1.4

16.3

693

5049

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

16.2

150

721

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

16.2

201

1074

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

16.2

348

2184

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

16.2

1860

15864

A03

ICPC

Fever

1.5

16.1

628

4497

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.1

16.1

157

770

JF2AB

NOMESCO Finland

Colongraphy with X-ray

7.1

16.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

16.1

347

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

16.0

130

593

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

16.0

289

1731

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

16.0

128

581

C08CA01

ATC

amlodipine; oral

1.3

16.0

1402

11499

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

16.0

162

807

K63.3

ICD-10 Finland

Ulcer of intestine

21.0

16.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

15.9

487

3318

J01CA08

ATC

pivmecillinam; oral

1.3

15.9

1628

13647

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

15.9

227

1269

J01MA06

ATC

norfloxacin; oral

1.5

15.9

479

3254

D02AE01

ATC

carbamide; topical

1.8

15.9

234

1321

UJH02

NOMESCO Finland

Anoscopy

2.1

15.9

157

775

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

15.8

232

1308

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

15.8

264

1547

UJG02

NOMESCO Finland

Proctoscopy

2.6

15.8

350

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

15.8

310

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

15.8

664

4826

B01AC04

ATC

clopidogrel; oral

1.5

15.7

556

3905

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.9

15.7

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

4.9

15.7

U07

ICPC

Urine symptom/complaint other

1.6

15.6

337

2115

6410

FHL

Panprococolectomy and ileostomy

+∞

15.6

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

17.2

15.6

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.2

15.6

193

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

15.6

196

1053

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

15.5

391

2550

SPAT1153

SPAT

Removal of sutures

1.4

15.5

1128

8989

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

15.5

1151

9203

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

15.5

140

668

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.8

15.4

122

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

15.3

236

1350

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

15.3

270

1607

Z94.4

ICD-10 Finland

Liver transplant status

6.7

15.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

15.2

1091

8668

SPAT1104

SPAT

Monitoring of emergency patient

1.8

15.2

236

1353

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

15.2

296

1809

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

15.2

697

5143

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

15.2

146

713

N05BE01

ATC

buspirone; oral

2.3

15.2

114

504

E000006, ,

ATC

1.8

15.1

253

1483

K76.9

ICD-10 Finland

Liver disease, unspecified

3.1

15.1

207

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

15.1

187

999

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

20.1

15.1

N06AG02

ATC

moclobemide; oral

2.0

15.0

159

804

P76

ICPC

Depressive disorder

1.7

15.0

253

1486

SFA30

NOMESCO Finland

Three-surface restoration

1.3

15.0

1541

12895

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

15.0

396

2612

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

15.0

565

4019

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

14.9

1077

8562

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

14.9

104

445

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

14.9

222

1258

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

14.9

225

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

14.8

963

7532

R33

ICD-10 Finland

Retention of urine

1.8

14.8

245

1432

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

14.8

264

1577

M45

ICD-10 Finland

Ankylosing spondylitis

2.7

14.8

281

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

14.7

132

628

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

14.7

289

1772

A11

ICPC

Chest pain NOS

1.6

14.7

330

2094

Z00.0

ICD-10 Finland

General medical examination

1.4

14.6

711

5297

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

14.6

224

1281

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

80.4

14.6

P01

ICPC

Feeling anxious/nervous/tense

1.5

14.5

450

3075

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

14.5

763

5766

R21

ICPC

Throat symptom/complaint

1.4

14.4

769

5821

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

14.4

991

7818

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.8

14.4

257

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

14.3

154

784

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.3

1718

14654

R07.0

ICD-10 Finland

Pain in throat

1.7

14.3

271

1646

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.8

14.2

247

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

14.2

137

670

R74

ICPC

Upper respiratory infection acute

1.3

14.2

1196

9715

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

14.2

455

3130

R51.81

ICD-10 Finland

Facial pain NOS

2.3

14.2

105

462

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

14.2

262

1580

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.0

14.1

102

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

14.1

417

2818

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

14.1

152

775

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

14.1

158

817

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

14.0

241

1425

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

14.0

125

594

P74

ICPC

Anxiety disorder/anxiety state

1.9

13.9

179

968

WW200

NOMESCO Finland

Immunization

2.3

13.9

100

434

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

13.9

131

635

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

13.9

180

976

WW500

NOMESCO Finland

Blood transfusion

2.0

13.9

147

744

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

13.8

103

454

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

13.8

285

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

13.8

152

780

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

13.8

283

1753

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

13.8

1775

15250

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

13.8

297

N01

ICPC

Headache

1.5

13.7

417

2834

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

13.7

695

5210

SPAT1138

SPAT

Guidance concerning bowel function

2.8

13.7

241

XX9XE

NOMESCO Finland

Other ultrasound examination

3.7

13.7

118

C03DA01

ATC

spironolactone; oral

1.5

13.7

436

2994

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

13.7

142

714

N03AX11

ATC

topiramate; oral

2.4

13.6

413

107

Kela drug reimbursment

Pernicious anaemia

2.8

13.6

253

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

13.6

188

1041

EB1VA, ,

NOMESCO Finland

1.4

13.6

652

4841

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

13.6

305

1933

R03BA05

ATC

fluticasone; inhalant

1.4

13.6

646

4791

K08.80

ICD-10 Finland

Toothache NOS

1.6

13.5

328

2118

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

13.5

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

13.5

K03.66

ICD-10 Finland

Tooth plaque

1.6

13.5

290

1817

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

5.4

13.5

L02

ICPC

Back symptom/complaint

1.5

13.5

389

2614

SPAT1255

SPAT

Intravenous administration of medicine

1.7

13.5

237

1409

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

13.5

153

794

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

13.5

486

3422

R12

ICD-10 Finland

Heartburn

1.6

13.5

319

2049

D05AX52

ATC

calcipotriol, combinations; topical

1.8

13.5

185

1023

X58

ICD-10 Finland

Exposure to other specified factors

1.5

13.4

521

3720

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

13.4

464

3239

N06AA12

ATC

doxepin; systemic

1.8

13.4

187

1039

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

13.4

319

2052

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.2

13.4

159

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.3

13.4

149

K86.8

ICD-10 Finland

Other specified diseases of pancreas

6.1

13.4

D07XC01

ATC

betamethasone; topical

1.5

13.4

412

2809

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

13.4

159

839

N06AX05

ATC

trazodone; oral

2.3

13.3

436

U71

ICPC

Cystitis/urinary infection other

1.6

13.3

281

1754

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

13.3

174

947

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.3

970

7703

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

13.3

203

1160

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

13.3

678

5089

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.7

13.1

258

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

13.1

277

1730

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.9

13.1

D29

ICPC

Digestive symptom/complaint other

2.3

13.0

434

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

13.0

537

3879

D01BA02

ATC

terbinafine; oral

1.4

13.0

869

6807

L86

ICPC

Back syndrome with radiating pain

1.7

13.0

237

1424

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

12.9

176

970

U02

ICPC

Urinary frequency/urgency

1.4

12.9

579

4246

R03BA02

ATC

budesonide; inhalant

1.4

12.8

641

4790

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

12.8

349

2317

R03BA08

ATC

ciclesonide; inhalant

1.6

12.8

322

2099

K20

ICD-10 Finland

Oesophagitis

2.6

12.7

268

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

12.7

310

2005

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

12.7

180

1005

-54

ICPC

Repair/fix-suture/cast/prosth device

2.4

12.7

358

L43.8

ICD-10 Finland

Other lichen planus

2.5

12.7

304

N20.1

ICD-10 Finland

Calculus of ureter

2.1

12.6

122

598

A02BA04

ATC

nizatidine; systemic

1.7

12.5

258

1600

K29.6

ICD-10 Finland

Other gastritis

3.0

12.5

176

H01

ICPC

Ear pain/earache

1.5

12.5

435

3039

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.5

12.5

318

SPAT1216

SPAT

Assessment of functional ability

1.4

12.5

545

3978

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

12.5

221

1318

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

12.5

149

788

SPAT1229

SPAT

Assessment of need for aid

1.6

12.4

272

1713

D09

ICPC

Nausea

1.8

12.4

181

1019

R31

ICD-10 Finland

Unspecified haematuria

1.6

12.4

317

2072

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

12.4

410

2835

120

Kela drug reimbursment

Hypogammaglobulinaemia

13.2

12.4

S21

ICPC

Skin texture symptom/complaint

1.4

12.4

562

4129

F33

ICD-10 Finland

Recurrent depressive disorder

2.3

12.3

375

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

12.3

157

848

UJF32, ,

SPAT

2.0

12.3

131

666

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

12.3

279

1775

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

12.3

367

2486

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.7

12.3

239

R4120

NOMESCO Finland

Occupational therapy

1.7

12.2

240

1471

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

12.2

116

565

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

12.2

171

952

G01AF05

ATC

econazole; vaginal

1.6

12.1

279

1779

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

12.1

213

1267

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

12.1

116

567

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

12.4

12.1

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.0

12.1

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

12.0

253

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

12.0

218

1309

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

12.0

135

700

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.4

11.9

319

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

11.9

289

1867

D16

ICPC

Rectal bleeding

2.2

11.9

432

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.8

11.9

220

ZX108

NOMESCO Finland

Inhalation

3.8

11.9

ZXA00

NOMESCO Finland

Right side

1.3

11.9

909

7253

W19

ICD-10 Finland

Unspecified fall

1.5

11.8

347

2340

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

11.8

369

2522

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

11.8

341

2292

L12

ICPC

Hand/finger symptom/complaint

1.4

11.8

636

4811

A29

ICPC

General symptom/complaint other

1.4

11.8

495

3586

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

11.7

1296

10857

E000002, ,

ATC

1.5

11.7

366

2500

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.0

11.7

162

R01AD11

ATC

triamcinolone; nasal

1.6

11.7

303

1988

R5110, ,

SPAT

1.5

11.7

332

2224

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

11.7

252

1583

G44.0

ICD-10 Finland

Cluster headache syndrome

3.1

11.7

152

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

11.6

325

2168

6525

FHL

Enterostomy occlusion

30.1

11.6

OAB50, ,

SPAT

1.6

11.6

283

1830

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

11.6

1179

9769

K90.4

ICD-10 Finland

Malabsorption due to intolerance, not elsewhere classified

12.6

11.6

N17.8

ICD-10 Finland

Other acute renal failure

2.9

11.6

179

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

11.5

259

1642

N06AX22

ATC

agomelatine; oral

2.2

11.5

412

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

11.5

236

1462

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

11.5

1037

8456

E000003, ,

ATC

1.9

11.5

149

809

J01MA01

ATC

ofloxacin; systemic

1.6

11.5

266

1699

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

11.5

401

2803

KED33

NOMESCO Finland

Transurethral incision of prostate

3.3

11.5

133

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

11.5

107

518

A10AB05

ATC

insulin aspart; parenteral

1.6

11.5

257

1629

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

11.4

128

662

K29.8

ICD-10 Finland

Duodenitis

3.6

11.4

104

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

11.4

208

1250

SPAT1139

SPAT

Nutrition survey

2.0

11.4

125

642

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

11.4

314

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.9

11.4

139

741

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

11.3

147

800

H92.0

ICD-10 Finland

Otalgia

1.6

11.3

239

1494

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

11.3

773

6064

M10.9

ICD-10 Finland

Gout, unspecified

1.7

11.3

220

1347

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.2

11.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

11.3

233

1448

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

11.2

104

502

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

11.2

469

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

577

1054

6.21

308.26

1.6

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

726

1091

7.88

307.65

1.6

1.4

266.29

283.88

ug/g

1.17

467

637

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

655

997

7.64

307.65

1.5

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

2461

4087

13.71

307.65

4.0

1.3

198.57

102.81

ug/g

21.17

2135

3123

(3024561) Albumin [Mass/volume] in Serum or Plasma

3003

16378

4.18

307.65

8.3

4.8

35.29

35.65

g/l

3.10

2890

15323

(3025941) Bacteria identified in Stool by Culture

965

1854

6.51

307.65

1.5

1.2

—

(3022145) Colonoscopy Study observation

2060

3642

10.43

307.65

1.7

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2105

8762

3.91

307.65

1.5

1.3

1.27

1.60

u/ml

0.70

566

2384

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1557

2414

9.83

307.65

2.1

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

798

1180

8.17

307.65

1.8

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1828

7536

3.59

307.65

1.8

1.5

2.34

2.39

g/l

0.34

1163

4599

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3147

19321

3.78

287.90

9.0

6.5

10.15

11.46

umol/l

9.36

3018

18396

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2241

11602

3.07

266.69

3.8

2.6

93.19

59.92

u/l

0.47

2120

10729

(3001604) Monocytes [#/volume] in Blood

2981

18604

3.25

245.44

11.3

6.0

0.59

0.58

e9/l

1.73

2648

15867

(3013115) Eosinophils [#/volume] in Blood

3045

19241

3.32

245.27

11.6

6.3

0.19

e9/l

0.42

2739

16695

(3006315) Basophils [#/volume] in Blood

2985

18656

3.25

244.87

11.3

6.0

0.04

e9/l

0.02

2651

15900

(3019198) Lymphocytes [#/volume] in Blood

3013

19057

3.24

239.42

11.4

6.1

1.90

1.93

e9/l

0.51

2730

16674

(3019069) Monocytes/Leukocytes in Blood

2814

17175

3.07

237.44

11.6

6.3

8.80

8.79

0.04

2702

16082

(3006504) Eosinophils/Leukocytes in Blood

2805

17132

3.05

235.54

11.5

6.2

2.77

2.83

0.57

2683

16034

(3022096) Basophils/Leukocytes in Blood

2806

17142

3.05

235.51

11.7

6.3

0.68

0.03

2684

16026

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1928

9730

2.87

231.07

3.6

2.3

2.88

2.81

mg/l

0.67

1743

8399

(3018010) Neutrophils/Leukocytes in Blood

2799

17252

3.00

227.63

11.2

6.1

58.04

57.18

3.55

2712

16473

(3002030) Lymphocytes/Leukocytes in Blood

2835

17608

3.01

227.04

11.5

6.2

27.26

27.96

2.80

2740

16663

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3755

27770

5.58

224.31

15.5

7.9

78.03

79.54

u/l

1.46

3673

26326

(3013650) Neutrophils [#/volume] in Blood by Automated count

3154

20991

3.24

218.74

14.7

9.5

4.21

4.09

e9/l

2.18

2826

18112

(3014765) Yersinia sp identified in Stool by Organism specific culture

455

937

5.34

211.12

1.4

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

452

930

5.34

209.91

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

455

945

5.30

209.04

1.4

1.1

—

(40768797) Stomach Pathology biopsy report

1234

5164

2.99

205.20

1.4

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

297

423

7.50

199.57

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

293

414

7.55

198.26

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

284

399

7.58

193.08

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

290

418

7.39

192.70

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

283

397

7.59

192.65

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

282

395

7.60

192.22

1.6

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3591

26918

3.85

182.19

7.6

4.3

13.92

12.29

mm/h

9.09

3444

25182

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

217

10.10

181.04

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1216

5384

2.80

178.46

3.3

2.6

21.89

22.42

0.60

1143

4997

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

205

215

9.99

176.24

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1338

6289

2.68

173.85

3.3

2.6

12.46

12.99

umol/l

1.68

1265

5855

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1275

5866

2.71

172.74

3.3

2.5

2.31

2.33

g/l

0.50

1186

5418

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

439

1047

4.58

169.91

1.7

1.5

5.26

7.44

iu/ml

0.10

187

(3023368) Bacteria identified in Blood by Culture

1813

9969

2.48

167.94

6.0

4.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2632

17176

2.51

165.80

3.6

2.4

77.55

78.25

nmol/l

0.63

2456

15518

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2580

16925

2.43

156.78

9.4

6.5

1.21

mmol/l

1.19

2431

15618

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

106

27.88

156.46

3.9

2.3

8.09

5.62

mg/l

2.00

(3005719) IgG [Mass/volume] in Serum or Plasma

765

2806

3.13

156.23

3.4

2.9

10.29

10.48

g/l

0.51

718

2589

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2776

18850

2.49

155.60

10.2

7.1

1.21

1.22

mmol/l

0.46

2393

16301

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2620

17650

2.36

144.49

4.7

3.1

133.79

116.49

ug/l

1.44

2484

16498

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

703

4.99

144.07

4.8

5.7

429.29

570.62

iu/ml

0.26

(3032080) INR in Blood by Coagulation assay

2520

16726

2.33

143.49

16.0

14.8

1.18

1.24

inr

9.03

2150

13889

(3028026) IgM [Mass/volume] in Serum or Plasma

635

2198

3.24

142.20

2.1

1.9

1.23

1.38

g/l

0.77

590

2017

(3020961) Endomysium IgA Ab [Titer] in Serum

543

1746

3.43

136.78

1.2

1.1

62.14

139.28

titre

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

841

3520

2.75

133.12

3.0

2.2

0.21

g/l

0.18

793

3296

(3036481) Cortisol [Moles/volume] in Serum or Plasma

853

3603

2.73

132.58

2.9

2.2

361.24

381.48

nmol/l

2.12

813

3335

(3004716) Salmonella sp identified in Stool by Organism specific culture

534

1740

3.38

131.47

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1098

5282

2.48

130.12

1.6

1.4

531.74

543.19

titre

0.07

276

1140

(36660697) Celiac disease serology panel - Serum

759

3081

2.80

126.93

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1218

6257

2.35

123.60

4.9

3.4

0.81

0.82

mmol/l

2.05

1141

5879

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

22.46

119.95

2.7

2.3

177.31

188.59

au/ml

—

(3018418) pH of Serum or Plasma

1850

11472

2.12

115.92

5.7

4.1

7.40

0.99

1388

8217

(3021589) Normoblasts [#/volume] in Blood

2385

16337

2.11

113.85

20.4

11.2

0.00

e9/l

0.03

2005

13198

(36304419) Bacteria [Presence] in Urine

1663

9980

2.13

112.75

4.2

3.2

2561.26

71.86

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3164

24265

2.37

112.54

6.8

4.8

2630.46

1964.40

e6/l

0.12

325

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2406

16594

2.10

112.00

2.7

2.1

95.55

96.90

pmol/l

0.69

1378

8540

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1931

12297

2.09

111.33

4.5

3.2

35.74

34.06

u/l

0.21

1823

11615

(3013826) Glucose [Moles/volume] in Serum or Plasma

2910

21658

2.21

109.83

7.6

4.9

6.55

6.66

mmol/l

2.02

2819

20492

(3030467) Casts [#/volume] in Urine by Automated count

1708

10469

2.09

108.34

4.4

3.3

0.47

0.43

e6/l

0.27

1339

7646

(3002179) Metamyelocytes/Leukocytes in Blood

730

3136

2.62

107.76

6.1

4.2

0.67

0.73

0.23

277

920

(3021960) Folate [Moles/volume] in Serum or Plasma

1736

10786

2.06

105.33

2.0

1.7

21.05

20.58

nmol/l

0.59

1529

9140

(3037467) Urinalysis macro (dipstick) panel - Urine

3211

25062

2.33

104.90

6.7

4.7

1.86

2.95

0.81

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

10.27

104.68

1.4

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1882

12097

2.03

103.38

4.5

3.4

48.61

76.41

e6/l

0.83

1513

9166

(3017181) Myelocytes/Leukocytes in Blood

742

3290

2.54

102.12

6.5

4.4

0.81

0.86

0.23

279

972

(3000850) Epithelial cells [#/volume] in Urine

1430

8359

2.10

101.46

3.4

2.7

6.15

6.22

e6/l

0.06

1333

7605

(3003458) Phosphate [Moles/volume] in Serum or Plasma

966

4903

2.27

97.56

7.6

5.9

1.04

1.05

mmol/l

0.54

916

4550

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

878

4283

2.34

97.37

3.9

2.8

7.70

7.95

umol/l

0.14

755

3758

(3026782) Osmolality of Urine

1261

7120

2.12

97.32

3.7

2.9

502.22

521.60

mosm/kgh2o

2.61

1130

6237

(3021440) Promyelocytes/Leukocytes in Blood

711

3156

2.52

97.25

6.6

4.5

0.11

0.10

0.12

247

841

(3018095) Leukocytes [#/volume] in Urine

2063

13905

1.98

96.89

5.5

4.0

66.63

103.97

e6/l

2.61

1575

9666

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1145

6246

2.16

96.53

2.3

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

782

3638

2.42

96.51

3.2

2.4

150.33

49.90

u/l

0.45

679

3055

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

13.98

96.44

2.6

1.3

9.63

9.49

mg/l

0.06

(3025159) Blasts/Leukocytes in Blood

713

3183

2.50

96.27

7.0

4.7

0.39

0.20

0.22

236

787

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

866

4227

2.33

95.73

4.9

4.4

231.49

246.83

u/l

2.61

820

4015

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

11.13

93.04

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

142

208

7.04

92.43

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

508

1955

2.83

92.20

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

139

203

7.05

90.72

1.4

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1972

13289

1.94

90.56

3.7

3.5

2.35

2.36

mmol/l

3.45

1786

12096

(3017143) Hepatitis C virus Ab [Presence] in Serum

835

4101

2.30

90.45

1.7

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3067

24080

2.11

89.57

5.0

3.3

52.91

46.50

u/l

2.31

2899

22575

(3033658) Prothrombin time (PT) actual/Normal

1514

9387

1.98

88.40

6.5

4.1

90.97

90.68

0.17

1478

9175

(3009445) Proteinase 3 Ab [Units/volume] in Serum

427

1529

3.00

88.27

1.7

1.5

3.96

17.01

iu/ml

1.40

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2022

13823

1.92

88.08

5.2

3.8

31.24

90.83

ng/l

1.09

1445

9545

(3019309) Folate [Moles/volume] in Red Blood Cells

1111

6180

2.10

87.68

2.1

1.7

1237.04

1164.53

nmol/l

1.40

851

4712

(40760892) CBC W Ordered Manual Differential panel - Blood

1361

8152

2.01

87.58

7.9

4.5

—

(3035350) Ketones [Presence] in Urine by Test strip

2629

19664

1.95

86.48

5.5

4.0

6.14

4.26

estimate

0.21

716

4211

(3021601) Nitrite [Presence] in Urine by Test strip

2607

19450

1.95

86.34

5.4

4.0

0.00

estimate

1.08

698

4083

(3009261) Glucose [Presence] in Urine by Test strip

2639

19786

1.95

85.91

5.5

4.0

0.00

0.09

estimate

0.57

691

3959

(3007566) Smooth muscle Ab [Titer] in Serum

320

997

3.40

83.42

1.4

1.2

110.32

98.82

titre

0.11

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

109

136

8.21

81.56

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

109

136

8.21

81.56

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3943

35156

4.96

81.54

32.7

15.7

21.51

23.79

mg/l

5.35

3669

28943

(3044640) Blood type and Crossmatch panel - Blood

1804

12101

1.88

81.15

3.4

2.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

828

4240

2.20

80.03

3.2

2.7

1.77

1.81

0.54

744

3787

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

476

1915

2.68

78.73

1.2

1.1

14.58

1.41

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

308

971

3.35

78.71

1.7

1.4

6.36

18.71

iu/ml

—

(40768804) Tissue Pathology biopsy report

2099

14898

1.84

77.69

2.5

2.1

—

(3017732) Neutrophils [#/volume] in Blood

875

4632

2.13

77.42

4.0

3.2

4.32

4.50

e9/l

0.33

743

4013

(3034770) Mitochondria Ab [Titer] in Serum

311

997

3.29

77.33

1.4

1.2

298.57

1181.25

titre

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1001

5578

2.05

77.19

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

363

1285

3.00

76.24

1.4

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

115

8.62

75.64

1.2

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

225

593

3.96

75.12

1.7

1.6

0.66

0.81

g/l

1.10

172

456

(3026008) Bacteria identified in Urine by Culture

1751

11880

1.83

73.83

4.1

3.3

—

(3015736) pH of Urine

2162

15644

1.82

73.56

4.4

3.5

6.18

6.26

2.59

1173

8671

(3023520) Reticulocytes [#/volume] in Blood

674

3278

2.27

73.37

2.9

2.6

68.73

70.18

e9/l

0.46

494

2379

(3042936) Bacteria identified in Isolate by Culture

936

5214

2.03

71.53

2.6

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

861

4666

2.07

70.88

2.1

1.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

14.20

69.03

2.1

1.2

88.75

145.90

au/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2319

17325

1.79

69.00

3.6

2.8

—

estimate

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1699

11592

1.80

68.93

2.7

2.2

183.19

201.21

u/l

0.35

1632

10964

(3019550) Sodium [Moles/volume] in Serum or Plasma

3945

35790

4.38

66.49

33.6

18.7

139.27

139.68

mmol/l

19.62

3905

35105

(3020779) Urea [Moles/volume] in Serum or Plasma

658

3295

2.19

66.14

10.2

7.3

9.90

9.62

mmol/l

0.43

633

3165

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3388

28673

2.09

65.97

5.8

4.6

14.83

14.78

pmol/l

0.48

3189

26391

(3023103) Potassium [Moles/volume] in Serum or Plasma

3945

35863

4.31

64.71

33.8

18.9

3.94

3.97

mmol/l

6.48

3904

35109

(3035933) Granulocytes/Leukocytes in Blood

246

761

3.38

64.60

4.4

3.0

57.62

57.64

0.01

246

761

(3014111) Lactate [Moles/volume] in Serum or Plasma

667

3391

2.16

64.39

8.2

7.4

1.32

1.33

mmol/l

0.04

654

3329

(3007853) Bacteria identified in Skin by Aerobe culture

788

4307

2.03

62.54

2.2

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1401

9240

1.79

62.10

3.2

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1075

6565

1.87

61.19

2.0

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1277

8256

1.80

60.15

2.4

1.8

1.23

1.26

mg/l

0.14

1008

6362

(3029937) Albumin [Presence] in Urine by Test strip

1570

10793

1.74

59.62

5.9

4.2

0.00

estimate

1.94

676

3827

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

217

661

3.41

58.34

1.3

264.98

262.14

u/ml

0.04

125

403

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1211

7771

1.80

58.11

2.0

1.7

9311803.43

35816479.98

pmol/l

1.67

1031

6458

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3772

33781

2.60

56.95

28.4

15.4

80.18

80.76

ml/min/173m2

0.88

3613

31261

(3023420) DNA double strand Ab [Units/volume] in Serum

382

1610

2.51

56.75

2.0

1.9

7.30

7.41

iu/ml

0.02

369

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

304

1146

2.79

56.50

1.9

1.8

0.24

0.23

g/l

0.13

288

1094

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

502

2394

2.25

56.35

5.7

4.0

5.02

5.17

kpa

4.14

489

2292

(3009343) pH of Capillary blood

492

2331

2.26

56.10

5.7

4.0

7.41

7.42

0.19

425

1931

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

310

1190

2.74

55.63

1.9

1.8

1.20

1.19

g/l

0.17

296

1137

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

779

4417

1.94

54.91

2.1

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1571

10993

1.70

54.64

3.8

3.2

1431.15

1258.84

ng/l

0.98

1365

9465

(40761536) Microorganisms panel - Urine sediment

576

2942

2.12

54.28

5.8

4.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3722

33301

2.38

53.32

7.4

5.6

1.96

1.92

mu/l

0.16

3537

30929

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

9.66

52.18

1.3

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1388

9501

1.70

51.69

3.5

2.7

341.37

336.53

umol/l

0.92

1237

8379

(3020630) Protein [Mass/volume] in Serum or Plasma

598

3151

2.05

51.68

2.8

2.7

65.77

66.39

g/l

1.03

551

2902

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

380

1668

2.41

51.53

1.8

1.62

1.55

g/l

0.77

335

1447

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

51.14

2.4

0.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

120

266

4.62

50.20

1.3

1.1

295.00

270.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

120

266

4.62

50.20

1.3

1.1

231.07

149.47

titre

0.47

(3005322) IgE [Units/volume] in Serum or Plasma

502

2508

2.14

49.87

1.6

1.3

225.71

195.21

u/ml

0.31

466

2328

(3000991) Gas panel - Venous blood

605

3245

2.02

49.64

10.5

8.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

597

3.31

49.23

3.6

2.9

1627.75

851.45

u/ml

0.24

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

256

949

2.81

49.01

1.1

1.69

5.87

eliau/ml

1.78

117

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

333

1418

2.47

48.18

2.1

2.0

1.55

2.09

ug/l

0.48

306

1257

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2713

22254

1.66

47.94

3.4

3.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

663

3715

1.94

47.81

6.1

3.8

5.70

5.83

kpa

2.71

637

3624

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

124

294

4.32

47.65

1.5

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

428

2051

2.21

47.11

5.8

3.9

1.41

1.91

mmol/l

2.01

315

1528

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1159

7711

1.70

47.07

3.3

2.9

2.46

2.45

mmol/l

0.71

1047

6940

(3012544) pH of Venous blood

665

3752

1.92

46.90

6.0

3.8

7.37

7.38

1.48

357

2134

(3048929) Epstein Barr virus Ab [Presence] in Serum

282

1125

2.62

46.74

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

166

5.52

46.54

2.8

1.7

1.95

1.97

umol/l

0.07

149

(3002032) Base excess in Venous blood by calculation

647

3628

1.93

46.44

6.1

3.8

1.35

1.87

mmol/l

2.83

576

3183

(40758558) Short blood count panel - Blood

1564

11280

1.63

46.22

9.6

6.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1026

6632

1.73

46.15

1.4

1.3

9.50

11.45

u/ml

0.44

394

2559

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1021

6599

1.73

45.90

3.8

2.9

1.17

e6/l

0.01

557

3463

(3015171) Extractable nuclear Ab [Units/volume] in Serum

343

1513

2.38

45.86

1.3

1.2

0.78

0.95

u/ml

0.13

117

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

659

3736

1.91

45.71

4.7

3.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

950

6025

1.75

45.65

4.1

3.0

3.87

3.01

e6/l

0.92

486

2882

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

183

587

3.22

45.20

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

521

2758

2.02

44.02

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

557

3019

1.98

44.01

5.7

3.8

1.22

1.23

mmol/l

3.30

507

2597

(3012501) Base excess in Blood by calculation

208

730

2.95

43.99

5.2

4.3

2.67

2.71

mmol/l

0.09

150

501

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

443

2209

2.13

43.97

6.5

4.0

23.87

24.30

mmol/l

2.09

431

2188

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1916

14626

1.59

43.95

5.4

3.9

0.05

0.23

estimate

0.58

604

3330

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1077

7143

1.69

43.69

1.5

1.3

32.85

31.27

iu/ml

0.13

317

2174

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

460

2341

2.09

43.24

2.0

1.7

—

(3013512) EKG study

1701

12665

1.59

43.17

4.4

3.6

0.40

0.73

—

(3004809) Band form neutrophils/Leukocytes in Blood

176

568

3.19

43.03

3.4

3.7

1.53

1.50

0.04

161

518

(1616796) Gas panel - Central venous blood

217

789

2.85

43.02

3.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

296

1258

2.46

42.91

3.1

24.16

24.98

mmol/l

3.00

291

1237

(3000494) Fungus identified in Specimen by Culture

752

4526

1.81

42.90

1.7

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3957

37011

3.53

42.15

22.4

11.9

25.40

25.45

u/l

0.08

3914

35953

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

93.09

41.83

1.1

1.0

20.11

—

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

131

359

3.74

41.29

1.2

51.21

59.36

u/l

1.11

117

313

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

185

642

2.97

39.91

1.8

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3967

37270

3.59

39.71

38.5

20.5

79.16

75.54

umol/l

8.19

3949

36840

(3052851) Hemolysis interference index of Serum or Plasma

241

984

2.54

37.99

3.7

3.4

2.48

2.06

index

0.41

118

509

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

151

480

3.23

37.85

1.1

1.49

1.51

g/l

0.28

143

434

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

234

960

2.53

36.51

2.2

2.0

11.97

11.81

mg/l

0.10

214

895

(3024354) Oxygen [Partial pressure] in Venous blood

547

3126

1.87

36.43

5.6

3.3

4.42

4.56

kpa

0.75

525

3043

(3041096) Erythrocytes [Presence] in Urine by Automated

1421

10453

1.55

36.24

4.7

3.4

0.10

0.20

estimate

0.33

587

3246

(4035726) Immunohistochemistry procedure

568

3290

1.84

36.23

1.6

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

378

1907

2.08

36.13

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

864

5646

1.67

36.07

3.1

2.2

29.98

29.56

1.07

834

5485

(3028192) IgG subclass 2 [Mass/volume] in Serum

127

374

3.47

35.96

1.4

2.64

2.86

g/l

0.63

274

(3024139) IgG subclass 3 [Mass/volume] in Serum

127

374

3.47

35.96

1.4

0.35

0.40

g/l

0.77

271

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

371

1862

2.09

35.95

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

127

375

3.46

35.82

1.4

6.63

6.73

g/l

0.08

271

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

230

945

2.52

35.77

1.7

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

191

718

2.74

35.53

1.4

—

(3045414) Leukocytes [Presence] in Urine

611

3659

1.79

34.82

2.7

2.1

0.05

0.01

estimate

0.54

110

786

(4062490) Immunoglobulin typing, IgG

124

368

3.44

34.70

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

234

989

2.45

34.24

1.8

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

175

641

2.81

34.20

1.5

1.4

159.54

147.59

au/ml

0.50

190

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

477

3.09

33.70

1.8

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

33.37

2.8

0.0

2.51

—

mg/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

632

3875

1.75

33.07

4.2

11.03

21.43

ug/l

1.12

493

3120

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

210

860

2.52

32.87

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

233

1004

2.40

32.66

2.0

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

170

629

2.78

32.60

1.3

121.33

271.37

titre

0.97

(3019977) pH of Arterial blood

680

4300

1.70

31.71

8.9

7.5

7.42

0.65

358

2323

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

263

1215

2.25

31.36

2.4

2.8

—

(3003181) Sodium [Moles/volume] in Urine

188

747

2.59

31.33

2.0

1.4

60.46

62.47

mmol/l

0.29

145

610

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

252

1149

2.27

31.00

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

247

1118

2.29

30.92

5.1

4.1

1.61

1.51

mg/l

1.14

226

1020

(44816559) Phosphatidylethanol [Mass/volume] in Blood

297

1460

2.12

30.28

1.9

1.6

0.31

mg/l

0.05

133

664

(3041672) Baker's yeast Ab [Presence] in Serum

58.81

30.09

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

279

1344

2.16

29.97

2.7

2.2

302.22

589.10

ug/l

1.04

258

1264

(3034860) Kappa light chains.free [Mass/volume] in Serum

266

1259

2.19

29.87

3.6

3.5

264.90

52.88

mg/l

0.51

219

1088

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

289

1420

2.11

29.49

1.6

13.54

15.88

u/ml

0.43

316

(3032057) Clostridioides difficile [Presence] in Stool

7.05

29.23

1.9

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

264

1257

2.18

29.20

3.6

3.5

36.88

63.58

mg/l

1.32

216

1086

(3027801) Oxygen [Partial pressure] in Arterial blood

670

4309

1.66

29.08

8.9

7.4

12.38

12.45

kpa

0.15

641

4143

(3014148) Varicella zoster virus Ab [Titer] in Serum

128

435

3.01

28.68

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

123

5.02

28.63

2.0

2.3

238.57

22148.59

u/ml

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

668

4309

1.66

28.62

9.0

7.4

4.97

5.11

kpa

3.41

641

4145

(3003396) Base excess in Arterial blood by calculation

662

4273

1.66

28.26

8.9

7.4

0.42

0.96

mmol/l

2.38

548

3528

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

310

1589

2.03

28.22

2.2

1.9

39.59

39.38

u/l

0.06

265

1432

(3044889) 12 lead EKG panel

2872

25111

1.49

28.04

5.1

4.1

0.38

7491.87

—

(3016502) Oxygen saturation in Arterial blood

604

3814

1.69

28.04

9.3

7.8

96.09

95.58

1.34

579

3685

(3014051) Protein [Presence] in Urine by Test strip

1386

10564

1.47

27.99

3.6

3.0

0.07

0.03

0.23

256

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

465

2.90

27.75

1.8

1.5

—

(3011412) CD3 cells [#/volume] in Blood

107

334

3.26

27.68

2.3

2.4

1269.91

1209.46

e6/l

0.25

294

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

1456

2.06

27.57

2.9

2.4

2.95

2.92

g/l

0.14

265

1324

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

203

3.95

27.35

1.3

1.2

104.68

80.24

u/l

1.15

169

(40768443) Skin Pathology biopsy report

320

1678

1.98

27.30

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

272

1345

2.10

27.27

2.8

2.4

0.88

g/l

0.01

234

1159

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

200

873

2.36

27.22

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

844

2.38

27.05

1.6

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

1116

2.18

26.54

3.6

3.3

3.08

2.83

ratio

0.09

141

644

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

712

2.48

26.32

1.6

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

134

491

2.79

26.20

1.1

1.73

3.17

eliau/ml

1.51

214

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

497

3032

1.73

26.08

4.8

3.7

88.29

87.70

ng/l

0.05

434

2595

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

197

3.91

26.00

1.3

1.2

27.38

21.00

u/l

0.55

160

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

287

3.37

25.92

1.6

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

1549

1.99

25.71

2.9

2.4

3.55

3.70

g/l

1.17

272

1418

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

1550

1.99

25.66

2.9

2.4

4.19

4.22

g/l

0.21

273

1416

(3006922) Hepatitis E virus Ab [Presence] in Serum

279

3.39

25.65

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

1551

1.99

25.62

2.9

2.4

7.49

7.42

g/l

0.24

273

1416

(3045424) Erythrocytes [Presence] in Urine

339

1854

1.90

25.52

2.8

2.1

0.01

0.42

estimate

0.50

608

(3006184) Hemoglobin [Mass/volume] in Capillary blood

199

893

2.29

25.41

2.8

2.3

127.17

128.39

g/l

0.27

147

709

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

275

1402

2.03

25.37

2.4

1.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

120

423

2.89

25.22

2.6

3.3

4.10

18.55

nmol/l

0.57

114

407

(3022313) Gas panel - Capillary blood

309

1646

1.95

25.16

6.8

4.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

630

4129

1.62

25.07

1.9

1.8

1.55

1.46

1.70

550

3637

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3591

33251

1.68

24.61

7.3

6.3

39.32

39.08

mmol/mol

0.81

3373

31134

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

206

3.74

24.43

1.6

1.5

5.03

6.94

u/l

0.62

164

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

234

1144

2.11

24.16

2.9

2.3

0.08

0.02

g/l

0.70

205

1035

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

239

1181

2.09

23.99

1.3

1.2

32.75

47.90

u/ml

0.36

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

987

7214

1.49

23.89

5.0

3.9

428.18

393.81

ng/l

0.06

741

5544

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

143

568

2.57

23.88

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

105

355

3.01

23.79

3.7

4.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

176

772

2.34

23.70

3.1

2.8

31.91

35.16

umol/l

0.88

164

700

(3002173) Hemoglobin [Mass/volume] in Arterial blood

554

3565

1.64

23.63

9.8

8.2

118.56

120.79

g/l

1.72

543

3479

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3648

33987

1.71

23.57

5.9

5.2

5.90

mmol/l

0.01

3386

31291

(3007461) Platelets [#/volume] in Blood

3978

38195

2.88

23.43

46.0

24.1

261.02

253.91

e9/l

8.58

3944

37457

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3978

38200

2.87

23.33

45.7

24.1

91.56

91.05

9.71

3962

37803

(3035941) MCH [Entitic mass]

3978

38201

2.87

23.31

45.6

24.0

30.31

30.27

0.68

3961

37802

(3016650) Hepatitis A virus Ab [Presence] in Serum

149

611

2.49

23.28

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3978

38205

2.86

23.23

46.8

24.6

39.42

40.35

6.51

3962

37790

(3026361) Erythrocytes [#/volume] in Blood

3978

38205

2.86

23.23

45.8

24.1

4.35

4.46

e12/l

41.16

3934

37342

(3010813) Leukocytes [#/volume] in Blood

3978

38210

2.86

23.13

45.9

24.2

7.01

6.73

e9/l

9.65

3938

37343

(3000963) Hemoglobin [Mass/volume] in Blood

3978

38215

2.85

23.03

46.3

24.3

130.47

134.19

g/l

49.42

3961

37830

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

225

1106

2.09

22.90

1.3

4.29

5.48

u/ml

0.14

104

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

226

1114

2.09

22.83

4.0

2.7

3.66

3.55

g/l

0.48

219

1058

(3019225) pH of Specimen

546

3539

1.63

22.56

5.1

4.4

7.36

7.35

0.62

407

2510

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

224

1107

2.08

22.47

1.3

9.63

7.03

u/ml

0.16

167

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

222

1102

2.07

22.01

2.9

2.3

0.00

g/l

-0.00

188

972

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

256

1342

1.97

21.81

3.9

3.4

314.51

3311.95

u/ml

0.83

224

1145

(3017354) Segmented neutrophils/Leukocytes in Blood

102

357

2.90

21.76

3.4

3.8

58.45

57.68

0.13

314

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

249

1298

1.98

21.56

2.3

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

151

4.02

21.43

39.7

40.8

6.88

7.38

ug/l

0.82

137

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

162

717

2.31

21.39

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

209

3.49

20.95

1.7

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

248

1304

1.96

20.94

7.5

4.2

24.28

24.87

mmol/l

2.29

233

1195

(3010375) cycloSPORINE [Mass/volume] in Blood

141

4.09

20.84

29.2

27.4

117.83

113.66

ug/l

0.15

116

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

3.31

20.59

1.7

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

425

2650

1.67

20.36

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

356

2.83

20.12

3.9

3.4

14.38

12.44

index

0.76

200

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

276

3.09

20.04

1.8

1.6

—

(3036489) Thrombin time

261

1418

1.90

19.99

3.5

2.2

21.69

21.00

0.50

232

1250

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

443

2805

1.65

19.98

1.6

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

399

2461

1.69

19.90

3.8

3.4

4.27

4.48

pmol/l

4.73

353

2209

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

372

2252

1.72

19.87

10.5

9.2

23.83

24.35

mmol/l

2.22

362

2211

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

217

3.36

19.79

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

269

3.09

19.62

2.5

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

234

3.25

19.51

2.1

2.5

191.80

218.90

e6/l

0.70

199

(3045683) HLA typing for celiac disease panel - Blood or Tissue

217

3.31

19.10

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

6.95

19.08

2.1

1.4

—

(3008898) HLA-B27 [Presence]

238

1274

1.92

19.06

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

210

1077

2.00

19.05

4.7

2.7

211.01

189.25

2.34

198

1029

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1030

2.02

18.97

3.1

2.3

0.00

g/l

-0.00

188

971

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1345

1.89

18.78

2.8

2.4

10.36

10.24

g/l

0.14

219

1200

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3217

29516

1.43

18.39

36.7

19.6

13.93

13.62

29.13

3204

29116

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

163

781

2.13

17.77

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

177

876

2.07

17.72

1.3

1.2

32.65

44.97

u/ml

0.61

100

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

229

3.14

17.52

2.1

2.4

569.95

529.04

e6/l

0.20

183

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

446

2939

1.58

16.98

2.7

2.3

6.63

6.90

ug/l

0.10

386

2599

(3000012) Reticulocyte production index

118

505

2.38

16.88

2.7

2.1

0.82

0.90

0.93

343

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

188

972

1.98

16.69

1.3

1.2

—

7.03

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

342

2122

1.67

16.61

11.8

9.9

15.62

15.90

1.16

335

2042

(3026389) Candida sp identified in Specimen by Organism specific culture

123

544

2.30

16.33

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

215

1172

1.88

16.31

3.8

2.4

89.05

93.29

1.78

210

1130

(3002256) Pathology report gross observation

689

5015

1.45

16.28

1.4

1.3

—

(3016038) Potassium [Moles/volume] in Urine

263

2.89

16.03

1.8

1.2

31.60

35.19

mmol/l

0.61

231

(3034274) Bile acid [Moles/volume] in Serum --fasting

107

451

2.41

15.85

1.9

2.4

9.66

6.85

umol/l

0.59

332

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

294

2.76

15.69

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

154

759

2.07

15.62

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

107

459

2.37

15.26

2.6

3.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

5.50

15.23

1.4

1.6

25.94

45.05

pmol/l

0.77

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

774

2.04

15.18

4.5

3.3

325.96

760.48

u/ml

0.62

145

715

(3018333) Ribosomal P Ab [Presence] in Serum

288

2.74

15.17

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

370

2.52

15.09

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

112

493

2.31

15.06

9.2

6.4

13.00

11.93

mg/l

1.31

101

459

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

434

2921

1.54

14.99

3.7

2.7

63.15

65.75

ml/min/173m2

0.64

217

1257

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

133

630

2.15

14.97

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

308

2.66

14.89

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

155

780

2.03

14.87

1.7

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.65

14.80

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

174

914

1.94

14.78

1.3

1.2

21.43

3.12

u/ml

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

440

2998

1.52

14.34

2.9

2.4

0.46

0.44

e6/l

0.07

421

2855

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

303

2.64

14.29

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

315

2.60

14.25

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

181

977

1.89

14.18

4.7

3.1

58.92

61.42

0.66

167

947

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

323

2.57

14.07

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

100

433

2.34

13.99

1.3

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

123

584

2.14

13.79

1.3

0.21

0.35

nmol/l

0.65

(3004119) Hemoglobin [Mass/volume] in Venous blood

352

2304

1.58

13.73

5.4

3.2

124.41

128.95

g/l

3.40

344

2236

(3009508) Creatinine [Moles/volume] in Urine

1522

12830

1.30

13.65

3.8

3.4

7.21

7.25

mmol/l

0.10

1286

10848

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

199

2.99

13.57

1.2

1.1

—

(40768441) Liver Pathology biopsy report

260

2.72

13.50

1.8

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

109

498

2.22

13.46

1.3

0.19

0.21

nmol/l

0.24

393

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3699

35313

1.52

13.11

6.4

5.8

2.62

2.72

mmol/l

10.05

3464

32929

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

182

3.05

13.08

1.1

1489.04

1597.73

miu/ml

0.29

182

(3020682) Albumin/Creatinine [Ratio] in Urine

1443

12131

1.29

13.06

4.6

4.1

12.07

8.37

mg/mmol

1.95

918

7393

(3003129) Base excess in Capillary blood by calculation

416

2.31

12.98

2.2

-0.06

0.76

mmol/l

1.04

400

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

857

6705

1.35

12.92

1.7

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

440

2.26

12.64

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

496

3566

1.45

12.30

2.5

2.1

—

(3012516) Albumin [Mass/volume] in Urine

1414

11934

1.28

12.19

3.8

3.5

59.41

45.74

mg/l

1.48

922

7457

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

155

3.12

11.93

2.6

2.2

127.88

136.89

umol/l

0.08

(3011985) Renin [Units/volume] in Plasma

109

524

2.11

11.89

1.6

1.4

74.03

80.63

mu/l

0.09

101

466

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

439

2.22

11.87

3.2

2.2

37.93

22.64

mg/l

1.45

167

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3485

33005

1.39

11.87

4.7

4.3

1.32

1.28

mmol/l

3.40

3235

30367

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

138

725

1.94

11.78

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

138

725

1.94

11.78

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

216

1302

1.70

11.72

2.8

2.2

5016.91

5490.94

u/l

0.08

518

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

533

3922

1.41

11.60

2.6

2.2

—

(3008295) Osmolality of Serum or Plasma

438

2.20

11.53

1.4

1.5

274.46

277.71

mosm/kgh2o

0.52

331

(3018405) Lactate [Moles/volume] in Arterial blood

196

1160

1.72

11.37

5.4

3.6

1.34

1.38

mmol/l

0.17

191

1143

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

134

3.23

11.34

1.3

1.2

0.33

0.29

g/l

1.80

109

(3037692) Legionella sp identified in Specimen by Organism specific culture

110

3.48

11.24

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3640

34801

1.44

11.12

5.7

5.1

4.56

4.67

mmol/l

8.44

3422

32575

(3010838) Calcium [Moles/time] in 24 hour Urine

130

687

1.92

10.93

1.8

1.9

4.87

5.01

mmol/24h

0.20

118

599

(3042733) HLA Ab [Presence] in Serum

103

3.52

10.85

5.2

4.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

123

640

1.95

10.83

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.25

10.78

1.3

1.2

1.60

1.41

iu/ml

—

(3037121) Protein [Mass/volume] in Urine

208

1270

1.67

10.77

4.3

3.4

240.17

418.42

mg/l

1.65

118

526

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

392

2.22

10.76

1.9

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

165

945

1.78

10.75

1.4

12.34

11.02

u/l

0.47

134

758

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.97

10.74

1.3

1.1

83.89

72.24

—

(21494814) CD8 cells/Lymphocytes in Specimen

144

3.08

10.72

2.3

2.1

31.11

29.84

0.23

144

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

195

1176

1.69

10.58

4.6

3.2

0.33

0.35

iu/ml

0.60

105

658

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.02

10.51

3.2

1.6

1.21

1.35

umol/l

0.46

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3617

34597

1.41

10.49

5.6

5.0

1.47

1.49

mmol/l

1.58

3389

32188

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

116

3.30

10.38

3.1

2.6

0.61

0.62

mmol/l

0.22

116

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1756

15420

1.24

10.27

2.1

1.9

1.40

1.35

mmol/l

1.64

1435

13000

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

440

2.12

10.22

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

476

2.06

10.08

1.3

—

nmol/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.44

10.03

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.84

9.93

1.3

1.1

89.80

79.50

—

(3004616) Nuclear Ab [Presence] in Serum

487

2.04

9.85

1.4

1.3

—

(21494434) Karyotype in Bone marrow

330

2.27

9.79

1.2

—

(3004451) EKG impression Narrative

226

2.54

9.76

1.4

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

110

575

1.94

9.60

1.4

1.2

5.04

4.28

u/ml

0.18

194

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

280

2.34

9.33

1.5

1.4

26.21

22.28

u/ml

0.19

(3019230) Fractional oxyhemoglobin in Venous blood

146

843

1.76

9.30

6.1

2.8

59.99

61.61

0.35

146

838

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

364

2.17

9.26

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

370

2653

1.43

9.26

2.5

2.4

29.13

20.74

au/ml

0.53

267

(3020876) Protein [Mass/time] in 24 hour Urine

446

2.04

9.15

2.5

2.2

0.99

1.28

g/24h

0.63

255

(3049717) Cytology report of Urine Cyto stain

198

1246

1.62

9.15

2.4

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

106

3.23

9.02

2.4

2.1

0.30

0.26

e9/l

0.15

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

568

4393

1.34

8.98

5.5

5.0

33.19

32.80

0.38

402

2917

(21494890) Protein electrophoresis panel - 24 hour Urine

363

2.14

8.93

2.5

2.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

404

2.08

8.86

2.1

1.6

60.51

57.99

0.24

257

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

358

2.14

8.83

1.9

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

494

1.97

8.80

1.4

1.3

314.12

323.66

pmol/l

0.08

421

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

215

2.48

8.70

1.7

1.4

5.69

6.86

u/l

0.63

187

(3036071) Salmonella sp Ab [Titer] in Serum

125

2.98

8.60

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

304

2.22

8.55

1.7

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

995

1.66

8.51

1.2

1.1

3.79

4.48

0.34

121

(4015189) Microbial culture of sputum

3.52

8.51

1.6

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

116

3.03

8.41

2.4

2.1

1.66

1.76

ratio

0.13

109

(3008152) Bicarbonate [Moles/volume] in Arterial blood

315

2235

1.44

8.35

9.2

6.4

24.01

24.54

mmol/l

1.58

305

2133

(3027273) Bicarbonate [Moles/volume] in Venous blood

239

1606

1.52

8.32

5.2

3.3

24.68

25.40

mmol/l

2.20

230

1550

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

321

2.17

8.30

1.2

108.62

109.52

pmol/l

0.06

321

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

178

1119

1.62

8.29

1.5

1.3

—

(3016228) CD19 cells/cells in Blood

145

2.78

8.21

2.3

2.0

8.25

8.00

0.06

138

(3028707) Methadone [Presence] in Urine by Screen method

107

586

1.85

8.16

1.9

2.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.36

8.14

1.0

0.03

0.06

u/ml

0.31

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

198

2.49

8.13

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

198

2.49

8.13

1.4

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

137

811

1.71

8.04

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

171

2.59

7.91

1.6

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

171

2.59

7.91

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

171

2.59

7.91

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

171

2.59

7.91

1.6

1.7

—

(3022621) pH of Urine by Test strip

397

2961

1.38

7.91

2.9

2.7

5.91

6.10

4.67

260

2000

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

947

1.65

7.84

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1218

10510

1.23

7.82

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

102

560

1.84

7.74

1.4

1.2

4.45

4.82

u/ml

0.10

248

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.92

7.69

1.3

1.1

75.07

88.98

0.93

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

292

2.18

7.68

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

292

2.18

7.68

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

292

2.18

7.68

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

491

1.89

7.63

2.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

102

3.05

7.57

1.6

1.5

0.40

0.39

ug/l

0.08

(3024471) HLA-A [Type]

102

3.05

7.57

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

334

2440

1.40

7.53

1.3

55.40

49.47

au/ml

0.19

157

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

7.11

7.46

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.54

7.41

2.2

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

171

2.53

7.40

1.5

1.8

3.09

4.07

u/field

0.28

123

(3016018) Differential panel - Cerebral spinal fluid

435

1.93

7.28

1.4

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

116

2.86

7.20

1.5

1.2

67.07

88.74

1.05

(3000475) Leukocytes [#/volume] in Synovial fluid

152

953

1.62

7.20

1.7

1.6

10959.24

12484.72

e6/l

0.20

119

660

(3024932) HLA-DR beta [Type]

100

3.01

7.18

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.30

7.18

1.4

1.3

0.22

0.28

iu/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

403

1.95

7.14

4.5

5.0

6.97

7.36

mmol/l

0.52

344

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

120

710

1.71

7.10

2.1

1.10

0.85

nmol/l

2.24

605

(44790048) Parainfluenza type 2 nucleic acid detection

489

1.86

7.09

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

489

1.86

7.09

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

489

1.86

7.09

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

489

1.86

7.09

1.7

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

188

1247

1.53

6.99

1.7

306.84

293.88

mu/l

0.21

169

1133

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

271

2.16

6.96

1.9

1.3

—

(3028433) Virus identified in Specimen by Culture

113

2.85

6.94

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

360

1.99

6.87

4.4

3.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.12

6.85

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

2.93

6.84

2.1

1.5

9.22

9.37

ug/l

0.07

103

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

154

982

1.59

6.82

1.7

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

156

998

1.59

6.81

1.3

1.4

503.01

540.79

mg/l

0.38

147

948

(3017569) Oxygen content in Arterial blood

203

2.33

6.81

1.9

2.3

16.06

16.27

0.16

203

(3044007) Cell count panel - Peritoneal fluid

120

2.76

6.79

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

482

1.84

6.78

1.2

1.3

113.82

51.36

u/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

138

2.62

6.70

1.9

2.3

911.27

988.10

e6/l

0.05

(3022493) Free Hemoglobin [Mass/volume] in Plasma

144

2.58

6.69

8.1

5.3

9835.64

71.51

mg/l

0.79

109

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

543

1.79

6.67

1.1

118.53

117.25

0.14

485

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

408

1.90

6.58

1.8

1.6

526.06

346.31

mu/l

1.17

326

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

2.63

6.54

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

2.63

6.54

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

253

1809

1.42

6.47

1.5

1.4

28.10

28.40

iu/l

0.05

220

1547

(3023511) Choriogonadotropin [Units/volume] in Urine

112

668

1.70

6.47

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

137

861

1.61

6.46

1.4

46.63

34.02

e6/l

0.19

109

633

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

293

2.06

6.46

1.2

0.81

1.62

u/ml

0.60

163

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

135

2.61

6.45

1.7

—

(3012565) Volume of 24 hour Urine

171

2.41

6.43

1.9

2.4

2026.20

1867.18

0.41

153

(3000093) Morphology [Interpretation] in Blood Narrative

342

1.98

6.39

1.2

1.1

—

(4268621) Lupus anticoagulant assay

406

1.89

6.35

2.5

2.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

515

1.78

6.33

2.1

1.9

—

6.89

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

2.27

6.30

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

331

1.98

6.25

3.7

2.9

—

(3019150) Specific gravity of Urine by Refractometry

1000

8621

1.21

6.24

5.5

4.2

1.02

1.19

kg/l

0.50

692

5763

(3016244) Insulin [Units/volume] in Serum or Plasma

232

2.17

6.15

3.6

3.3

23.63

23.99

mu/l

0.02

223

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

138

880

1.59

6.15

1.3

3.81

3.72

mmol/l

0.46

130

830

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.73

6.13

1.4

1.6

1.14

1.63

mg/l

0.18

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

137

876

1.58

6.04

1.5

795.64

1259.32

e6/l

0.37

116

691

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

301

2.01

6.03

2.1

1.8

4.44

4.18

mg/l

0.15

293

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

107

644

1.68

6.00

1.1

18.51

18.62

au/ml

0.00

150

(3047181) Lactate [Moles/volume] in Blood

163

1088

1.52

5.94

6.0

5.7

1.30

1.27

mmol/l

0.15

145

955

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

276

2.04

5.91

2.0

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

564

1.72

5.89

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

357

2743

1.33

5.88

1.3

1.2

118.00

144.40

u/ml

0.66

113

998

(3034891) Synovial lining cells/cells in Synovial fluid

160

2.39

5.87

2.1

1.3

3.93

3.81

0.02

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.01

5.79

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

376

1.88

5.78

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.57

5.67

1.5

1.6

1.96

4.51

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.57

5.67

1.5

1.6

1.48

2.30

mg/l

—

(3052592) Norovirus Ag [Presence] in Stool

3.40

5.58

1.6

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

403

1.83

5.55

2.4

31.15

34.29

iu/ml

0.05

(3009871) Measles virus Ab [Titer] in Serum

128

2.51

5.52

1.9

1.7

4640.00

4496.00

titre

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

117

2.58

5.45

1.4

127.89

127.36

nmol/l

0.00

(3011288) Drugs identified in Urine by Screen method Nominal

144

956

1.52

5.41

2.1

3.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

296

2242

1.35

5.38

2.9

3.7

46.33

70.93

u/ml

1.25

288

2163

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

142

2.41

5.37

1.1

9.88

7.82

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

167

2.29

5.36

1.6

1.3

171.08

153.51

mmol/24h

0.53

167

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.73

5.36

5.3

5.9

28.56

60.59

ug/min

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

226

1645

1.40

5.27

5.7

4.8

1.52

1.59

0.64

212

1550

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

188

2.19

5.24

1.3

1.1

—

(4195642) Thrombophilia screening test

538

1.69

5.23

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

432

3462

1.28

5.21

1.9

1.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.76

5.19

1.7

1.4

22.55

25.13

g/l

0.35

(3017446) Testosterone [Moles/volume] in Serum or Plasma

305

2340

1.33

5.10

2.5

2.3

12.37

12.93

nmol/l

0.50

267

2115

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

137

914

1.52

5.06

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

528

1.68

5.06

1.1

3.42

3.32

—

(44806071) Cardiolipin IgM antibody measurement

3.57

5.04

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

647

1.61

4.96

1.3

1.2

36.75

35.50

u/l

0.03

555

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

268

1.95

4.91

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

311

1.88

4.88

2.1

1.5

24.61

33.84

1.20

193

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

118

2.47

4.87

1.9

2.0

2436.83

20400.52

e6/l

0.53

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

208

2.08

4.83

2.7

39.70

42.67

0.52

109

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.22

4.81

1.3

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

159

1106

1.46

4.80

2.1

2.0

5.87

9.05

iu/l

0.25

459

(3001964) Herpes simplex virus Ag [Presence] in Specimen

108

2.51

4.70

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

710

0.47

4.69

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

549

1.64

4.63

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

205

2.06

4.63

1.5

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

4.30

4.62

1.1

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

104

2.51

4.54

1.4

1.5

11.40

13.11

g/l

0.48

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

141

970

1.47

4.52

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

682

0.48

4.44

1.5

1.21

1.27

0.27

486

(3047352) Trisomy 18 risk [Likelihood] in Fetus

694

0.49

4.42

1.6

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.21

4.33

1.2

1.4

5.87

648787.54

nmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

281

1.86

4.31

1.5

2.1

1.35

1.52

u/field

0.19

149

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

4.31

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

4.31

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

581

4923

1.21

4.22

3.2

3.3

0.73

0.75

ug/l

0.21

399

3197

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

933

8249

1.17

4.16

5.8

5.5

2.12

3.34

ug/l

1.54

844

7432

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.48

4.12

1.2

1.1

0.43

2.63

u/ml

0.70

(3016879) Cocaine [Presence] in Urine

174

1268

1.39

4.11

1.8

2.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

148

2.17

4.08

2.2

1.8

39.45

40.10

g/l

0.28

148

(4024509) Urine culture

239

1832

1.32

4.07

2.4

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

383

1.71

4.06

1.5

—

(3000330) Specific gravity of Urine by Test strip

242

1859

1.32

4.06

4.0

3.4

1.02

ratio

0.14

212

1671

(3020911) Cortisol [Moles/time] in 24 hour Urine

129

2.26

4.05

1.3

1.6

67.14

348.21

nmol/24h

0.70

129

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

2.41

4.05

4.2

2.9

4.83

kpa

0.01

104

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

2.41

4.05

4.2

2.9

10.53

10.46

kpa

0.05

104

(3038177) Helicobacter pylori Ab [Presence] in Serum

577

1.57

4.05

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.51

4.04

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

370

1.71

3.99

1.6

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

5.57

3.97

1.3

1.5

—

(40768795) Lymph node Pathology biopsy report

386

1.70

3.96

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

201

1510

1.35

3.94

6.0

5.0

0.85

0.88

0.42

189

1420

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

358

2908

1.25

3.89

3.5

3.0

198.88

192.48

ng/l

0.08

320

2658

(44806420) Estimation of glomerular filtration rate

411

1.67

3.89

2.7

2.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

529

1.58

3.85

1.5

1.4

23.59

28.64

u/l

0.82

440

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.27

3.82

1.8

3.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

221

1.91

3.81

1.0

1.1

0.56

17.41

u/ml

0.55

(3001186) Copper [Moles/volume] in Serum or Plasma

102

2.36

3.73

2.5

1.2

14.39

16.90

umol/l

1.81

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

4.15

3.70

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.01

3.68

1.1

—

(3023410) Appearance of Cerebral spinal fluid

387

1.66

3.67

1.5

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

149

1080

1.39

3.67

2.0

2.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.63

3.65

1.8

1.5

369.69

494.97

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

169

2.02

3.63

1.1

—

(3047189) Immunofixation for 24 hour Urine

176

2.00

3.63

2.5

1.5

—

(3027008) Opiates [Presence] in Urine

182

1368

1.35

3.58

1.8

2.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.75

3.58

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.75

3.58

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.75

3.58

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

177

1.99

3.58

2.6

2.4

—

(3000764) Benzodiazepines [Presence] in Urine

181

1360

1.35

3.57

1.9

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

337

1.70

3.57

1.2

1.4

367.85

335.27

u/l

0.19

325

(3013336) Amino acids [Identifier] in Serum or Plasma

7.79

3.55

3.9

4.6

—

(21494755) Public health laboratory ask at order entry panel

242

3061

0.78

3.55

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

461

1.59

3.54

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.05

3.52

16.7

12.6

5.39

5.57

mmol/l

0.07

(3009466) Valproate [Moles/volume] in Serum or Plasma

510

1.56

3.50

5.6

5.5

343.36

364.77

umol/l

0.63

450

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

492

4180

1.20

3.48

9.8

6.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

729

6407

1.17

3.47

1.6

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.89

3.46

1.2

1.6

—

(3028300) Cannabinoids [Presence] in Urine

182

1376

1.34

3.46

1.9

2.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

237

1.82

3.42

1.9

1.5

82.40

79.22

umol/l

0.25

237

(4281824) Cell count and differential, peritoneal fluid

442

1.59

3.41

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

4.08

3.39

3.5

3.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.51

3.37

1.2

1.1

0.88

0.73

umol/24h

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

154

2.02

3.34

1.6

2.0

2.61

0.98

u/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

255

1.77

3.29

1.2

1.3

12.35

11.15

u/l

0.29

234

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.58

3.26

1.2

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

393

1.61

3.24

1.0

1.1

—

49.20

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.74

3.23

2.0

2.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

103

2.24

3.22

1.3

1.2

42.61

38.89

g/l

0.76

(3003434) Protein [Mass/volume] in Pleural fluid

497

1.54

3.21

1.5

32.69

32.46

g/l

0.06

452

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

288

1.71

3.17

1.0

1.1

269.33

259.46

mg/l

0.06

251

(3028308) Erythrocytes [#/volume] in Pleural fluid

388

1.61

3.16

1.5

1.4

21767.93

65662.41

e6/l

1.53

212

(3020874) Milk IgE Ab [Units/volume] in Serum

229

1.80

3.15

1.1

1.12

3.72

u/ml

1.04

(3006270) Folate [Moles/volume] in Blood

296

1.70

3.15

1.1

1.2

389.57

376.05

nmol/l

0.17

258

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.26

3.13

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.54

3.12

1.5

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

118

2.13

3.09

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

299

1.68

3.05

1.1

1.2

34.56

38.98

mg/l

0.56

249

(3027944) Amphetamines [Presence] in Urine

176

1352

1.32

3.04

1.9

2.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.51

3.03

1.1

1.2

0.04

7.01

u/ml

0.53

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

290

2372

1.24

3.02

2.2

2.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.35

2.98

1.2

1.1

482.86

275.43

pmol/l

0.60

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

817

0.62

2.97

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

127

2.05

2.96

1.9

1.7

—

(3017704) Immunofixation for Urine

212

1.80

2.95

1.9

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

828

0.62

2.95

1.5

0.95

ratio

0.02

500

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

828

0.62

2.95

1.5

1.25

1.15

ratio

0.38

502

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

828

0.62

2.95

1.5

1.16

1.13

ratio

0.06

500

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.71

2.91

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

163

1.91

2.89

1.0

86.40

91.85

0.53

121

(3028717) Thiamine [Mass/volume] in Blood

2.70

2.88

1.2

71.36

67.54

ug/l

0.18

(4027681) Cerebrospinal fluid IgG ratio and IgG index

230

1.75

2.82

1.3

1.2

0.59

0.55

ratio

0.26

138

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.65

2.79

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

440

3779

1.18

2.79

1.5

—

(40768806) Pleura Pathology biopsy report

362

1.58

2.78

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

573

1.46

2.75

1.1

177.58

1091.64

iu/ml

0.44

124

(3015076) Soybean IgE Ab [Units/volume] in Serum

195

1.80

2.75

1.0

1.1

0.10

2.65

u/ml

0.85

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

152

1.91

2.74

2.6

3.5

0.86

1.24

1.17

152

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.71

1.4

1.1

43.19

78.87

ng/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

153

1.90

2.70

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

634

1.43

2.69

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

634

1.43

2.69

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

376

1.55

2.61

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

109

799

1.37

2.61

1.1

0.87

2.03

u/ml

1.56

430

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

184

1.80

2.60

1.5

1.6

—

(3034426) Prothrombin time (PT)

120

2.01

2.60

1.3

1.2

28.42

28.57

0.03

120

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

141

1.92

2.60

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

151

1164

1.31

2.59

1.4

1.3

178.48

220.43

miu/ml

0.76

555

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

252

1.67

2.58

1.1

0.54

14.55

nmol/l

1.54

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.01

2.56

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1165

0.71

2.56

1.1

0.55

0.63

ratio

—

149

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

114

2.02

2.55

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

253

1.67

2.54

1.3

1.4

118.00

515.50

titre

—

(3014271) Vancomycin [Susceptibility]

171

1.82

2.54

2.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

419

1.51

2.53

1.1

—

5.54

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

634

1.41

2.53

1.8

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.11

2.48

1.2

1.3

288.67

408.94

ug/l

0.11

(3025018) Bordetella pertussis Ab [Titer] in Serum

263

1.64

2.47

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

230

2797

0.81

2.46

1.7

3.26

3.49

mmol/l

1.94

144

1915

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

116

1.99

2.45

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.46

2.44

3.9

2.2

0.64

1.51

mmol/l

—

(4133840) Spirometry

2.24

2.44

1.4

1.1

—

(1002224) Polysomnography panel

204

1649

1.25

2.42

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

239

1967

1.23

2.40

2.0

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

751

0.65

2.40

6.1

3.5

31.20

26.54

mg/l

0.46

520

(3028679) Herpes simplex virus Ab [Presence] in Serum

204

1.72

2.40

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

893

0.68

2.39

1.5

66.01

58.89

ug/l

0.36

748

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

182

1.76

2.39

1.3

1.4

26.80

75.96

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.35

2.38

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1248

0.73

2.33

1.2

1.1

1.50

1.55

g/l

0.79

1248

(3000034) Microalbumin [Mass/volume] in Urine

300

1.57

2.30

3.8

3.2

38.65

36.75

mg/l

0.03

222

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

728

6588

1.13

2.26

4.2

4.5

21.63

21.76

0.08

348

3183

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.28

2.24

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.28

2.24

1.7

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

318

1.55

2.24

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1030

0.71

2.21

1.7

1.5

—

(3048879) Bone marrow aspiration report

2.05

2.21

1.1

1.8

—

2.00

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

272

1.59

2.19

1.6

1.5

0.99

1.20

promille

0.45

215

(40758292) HTLV I+II Ab panel - Serum

2.24

2.17

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

121

1560

0.77

2.17

1.5

1.6

1044.37

1000.89

mu/l

0.21

101

1306

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

273

1.58

2.17

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

426

0.56

2.16

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

370

1.49

2.15

1.3

1.4

6.84

6.46

mmol/l

0.40

352

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

274

1.58

2.14

1.1

4.23

9.08

iu/ml

1.25

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

588

1.39

2.12

1.6

1.5

0.29

0.39

nmol/l

1.10

454

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.26

2.07

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

2.01

2.5

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

444

1.43

1.97

1.5

1831.59

3979.17

e6/l

0.54

310

(42529582) MDA5 Ab [Presence] in Serum by Line blot

112

1.88

1.96

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

112

1.88

1.96

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

112

1.88

1.96

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

112

1.88

1.96

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

115

893

1.30

1.95

1.9

44.45

41.48

nmol/l

0.65

109

863

(3033942) Copper [Moles/time] in 24 hour Urine

3.75

1.93

1.0

1.1

—

0.20

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

685

1.34

1.92

1.1

5.77

4.36

u/ml

0.36

373

(44813793) Dust mix specific IgE antibody measurement

258

1.56

1.92

1.1

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

196

1.64

1.89

1.2

1.3

140.91

134.05

nmol/l

0.27

196

(3020650) Glucose [Presence] in Urine

129

1.79

1.85

1.9

0.13

0.05

estimate

0.27

129

(3044242) Glucose [Moles/volume] in Arterial blood

207

1.60

1.79

2.2

2.1

7.72

8.58

mmol/l

0.76

207

(3039000) Anion gap in Blood by calculation

746

1.31

1.79

7.8

6.7

11.56

11.18

mmol/l

0.62

665

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.76

1.79

2.4

2.7

—

(3018572) Chloride [Moles/volume] in Blood

747

1.31

1.77

7.8

6.7

104.02

105.14

mmol/l

1.11

666

(3021162) Amylase [Enzymatic activity/volume] in Specimen

2.09

1.75

2.4

3.2

115.93

2326.82

u/l

1.24

(3008401) Mugwort IgE Ab [Units/volume] in Serum

662

1.32

1.74

1.1

0.65

1.14

u/ml

0.77

291

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

170

1.65

1.73

3.5

4.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

637

1.33

1.72

1.1

1.19

1.58

u/ml

0.26

322

(40768446) Kidney Pathology biopsy report

140

1.72

1.71

2.4

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

329

3745

0.87

1.71

1.9

3.38

3.44

ratio

0.45

234

2855

(40757494) Bilirubin.total [Moles/volume] in Blood

194

1.60

1.71

4.7

2.9

20.42

46.91

umol/l

—

(4198724) Urine methamphetamine measurement

133

1.73

1.69

1.4

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.16

1.66

1.0

1.1

0.04

u/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.5

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.58

1.66

1.0

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.57

1.61

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

128

1.72

1.60

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

238

1.52

1.59

1.1

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1.55

1.59

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.00

1.58

1.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.70

1.58

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

255

1.49

1.57

2.1

2.0

6.32

6.74

mmol/l

0.63

166

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.20

1.56

1.0

1.1

45.92

39.13

mg/l

—

(3035880) pH of Pleural fluid

199

1.56

1.2

1.4

7.41

7.42

0.14

132

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

152

1.65

1.56

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

517

1.34

1.56

1.1

3.20

5.06

u/ml

0.65

230

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

297

1.45

1.55

1.3

1.4

9.34

8.80

mmol/l

0.30

283

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

772

1.28

1.55

2.9

2.3

42.73

105.26

ug/min

2.83

467

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.93

1.54

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

208

1.54

1.53

2.3

2.2

2.44

2.37

ug/l

0.05

175

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.34

1.52

1.8

4.5

—

(3016750) Collection duration of Urine

201

1.55

1.51

2.7

2.1

527.76

494.25

min

1.67

152

(3005011) Chlamydia sp Ab [Titer] in Serum

2.16

1.50

2.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

194

1.55

1.48

1.3

2.0

—

(4146454) Self-monitoring of blood glucose

385

1.38

1.47

3.0

2.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.13

1.44

1.0

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.73

1.43

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.73

1.43

1.3

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

336

1.40

1.43

1.5

1.4

116462.94

97234.53

e6/l

0.11

223

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

449

1.34

1.40

1.3

1.6

2.76

4.25

ug/l

1.24

381

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.18

1.39

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

181

1.55

1.39

1.8

1.4

176.15

215.11

pmol/l

0.30

181

(3022689) Creatine [Moles/volume] in Urine

119

1.68

1.37

1.5

9.66

7.63

mmol/l

0.71

119

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.20

1.37

1.0

1.1

0.04

0.03

u/ml

—

(3025130) Human papilloma virus identified in Specimen

601

1.29

1.34

1.7

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.10

1.30

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.85

1.29

1.6

1.4

1.16

1.17

mmol/l

0.25

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.76

1.28

1.1

3.4

97.82

132.39

ng/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.09

1.27

1.5

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

1.27

1.2

1.0

—

(3033099) Centromere Ab [Titer] in Serum

1.79

1.27

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

227

1.46

1.26

1.0

1.1

1.33

1.13

u/l

0.28

106

(3043410) Blood group antigens tested for on Red Blood Cells

107

1.69

1.25

1.6

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

564

1.28

1.24

1.1

1.00

4.45

u/ml

4.31

283

(3027456) Digoxin [Moles/volume] in Serum or Plasma

771

1.24

1.22

3.5

0.80

nmol/l

0.07

623

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.63

1.21

1.4

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.80

1.21

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

213

1.46

1.20

2.0

1.4

1.19

1.23

nmol/l

0.06

158

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

436

1.31

1.18

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

1.47

1.16

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.73

1.15

1.0

16.36

35.98

iu/ml

1.63

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

1.59

1.14

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

121

1017

1.20

1.12

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.34

1.12

1.4

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.00

1.12

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.26

1.10

2.0

2.6

0.14

0.74

u/field

—

(4211845) Urine protein measurement

176

1.48

1.10

3.7

3.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

161

1396

1.16

1.05

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

129

1.55

1.05

1.1

1.2

1155.56

1048.15

titre

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

263

1.37

1.03

1.0

773.50

719.24

ng/l

0.28

174

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

263

1.37

1.03

1.2

1.1

25.59

15.86

u/ml

0.93

111

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.06

1.02

1.0

1.2

11.57

11.94

u/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

265

1.36

0.99

1.0

32.59

43.66

ng/l

1.39

174

(3004775) Volume in Urine collected for unspecified duration

265

1.36

0.99

2.6

2.2

744.48

627.32

1.10

179

(3045788) Cell count panel - Pleural fluid

370

1.30

0.98

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

200

0.60

0.98

1.3

1.4

5.51

5.81

mmol/l

0.49

190

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

198

1.42

0.97

1.4

1.8

6.97

8.05

nmol/l

0.08

156

(3044009) aPTT.lupus sensitive (LA screen)

1.95

0.97

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

117

1.54

0.93

1.0

7.60

13.25

u/ml

0.78

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.22

0.93

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.65

0.88

1.7

2.1

20.46

17.10

umol/l

0.34

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

263

1.33

0.87

1.0

276.81

321.31

ng/l

0.72

177

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.86

0.87

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.86

0.87

1.9

2.3

—

(3006462) Nitrate [Presence] in Urine

162

1.42

0.84

3.5

3.7

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.76

0.83

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

171

1.41

0.83

1.7

2.1

19.60

160.11

ug/min

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

155

1.42

0.81

1.2

1.1

30.14

362.08

ng/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

491

1.23

0.79

1.1

0.22

0.28

u/ml

0.20

168

(44786800) Granulocytes/Leukocytes in Body fluid

1.82

0.79

1.3

1.4

34.00

15.48

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.67

0.78

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

581

0.81

0.74

1.5

62.72

60.62

ug/l

0.10

581

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.08

0.74

1.4

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

201

1.35

0.74

1.5

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

447

0.78

0.73

1.2

1.3

7.26

7.31

mmol/l

0.05

396

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.75

0.71

1.1

1.2

1.55

1.79

umol/24h

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

672

0.83

0.68

1.7

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.72

0.64

4.2

4.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

684

1.16

0.61

2.0

1.9

192.19

202.66

pmol/l

0.35

645

(3001019) Free T4 and TSH panel - Serum or Plasma

196

1795

1.10

0.61

1.9

1.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

140

0.64

0.60

2.6

2.4

188.67

153.26

nmol/l

—

123

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.60

0.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.53

0.59

1.8

1.6

—

(40768793) Breast Pathology biopsy report

118

1054

1.12

0.59

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

140

1.36

0.58

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.46

0.58

1.5

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

356

1.21

0.56

4.6

5.2

8.55

68.43

u/ml

2.32

107

(3041806) Other cells [#/volume] in Blood by Manual count

116

1.38

0.54

1.7

0.57

0.49

e9/l

0.61

116

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

739

0.86

0.53

1.5

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.47

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.49

0.47

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.37

0.47

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.43

0.45

2.4

2.5

4.18

49.83

ug/l

0.51

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.40

0.45

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.40

0.45

2.1

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

387

1.16

0.42

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

221

1.22

0.42

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

249

1.21

0.41

3.0

1.7

82.10

100.93

ng/l

0.82

249

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.52

0.41

1.4

1.3

5.98

5.88

mmol/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3024263) Appearance of Synovial fluid

187

1.23

0.39

1.4

1.7

—

(3019174) dRVVT (LA screen)

1.39

0.38

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.34

0.38

1.3

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.35

0.37

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.37

1.0

1.1

64.00

94.27

titre

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

108

1.30

0.35

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

823

1.10

0.35

5.5

4.4

—

(1761868) Lipid panel - Serum or Plasma

1389

13656

1.03

0.33

3.3

3.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

111

1.26

0.30

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

222

1.17

0.29

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.23

0.27

18.1

7.7

5.51

5.32

kpa

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

225

1.16

0.26

1.5

1.6

7.90

7.81

mmol/l

0.05

217

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

118

1253

0.94

0.25

1.5

—

(4034850) Laboratory test

117

1106

1.06

0.23

12.1

9.8

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.24

0.23

1.2

1.4

54.67

33.27

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.24

0.23

1.2

1.1

—

(3014891) Appearance of Pleural fluid

1.19

0.21

1.2

1.5

—

(3006598) pH of Arterial cord blood

1.19

0.21

1.4

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.09

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.20

0.19

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

196

0.87

0.18

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2962

29486

1.02

0.18

36.5

20.4

330.81

331.81

g/l

7.38

2953

29325

(40768800) Prostate Pathology biopsy report

523

1.07

0.17

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.13

0.16

2.8

3.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.21

0.15

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

226

1.11

0.15

1.8

—

(40765096) Chromosome analysis panel by Banding

132

1.14

0.13

1.3

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.04

0.09

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.08

1.7

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

128

1308

0.98

0.07

1.7

1.8

5.96

4.28

mg/l

0.65

108

983

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

177

1.07

0.06

1.2

14.11

9.63

mm/h

0.51

177

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

117

0.94

0.01

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

442

1.00

0.00

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.01

0.00

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

231

1.00

0.00

7.5

6.9

3.45

98.04

ug/l

0.66

141

(1617658) Protocol used for examination of sentinel lymph nodes

323

0.99

0.00

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

32.87

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

177.80

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1384.00

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1479.17

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

2.35

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.94

-0.00

1.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

2.03

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3001.29

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.00

-0.00

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.98

-0.00

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.0

—

77.32

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: COLITCOLLAG – Collagenous colitis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Collagenous colitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Collagenous colitis (COLITCOLLAG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints